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COXIELLA BURNETII:  BRIEF HISTORY OF DISCOVERY 
In 1935, contemporaneous research programs at the Rocky Mountain Laboratory 
(RML) in Hamilton, Montana; the Laboratory of Microbiology and Pathology in 
Queensland, Australia; and Queensland Health Department at Brisbane, Australia began 
the initial investigations into what was thought to be a filterable virus of the Rickettsiae 
family, but was later found to be the Gram-negative bacterium now known as Coxiella 
burnetii.   
Public demand around the turn of the 20th century in the mountains of the 
Bitterroot Valley of western Montana insisted that a cure to the local epidemic of the 
“spotted fever of the Rockies” led to the establishment of what today is known as the 
Rocky Mountain Laboratory (RML) [1].  In an effort to study the ecology of Rocky 
Mountain Spotted Fever (RMSF) and Tularemia, Dr. Ralph R. Parker, one of the 
founding members of RML [2], collected a sample of Dermacentor andersoni t cks from 
the nearby Saw Tooth Canyon in 1925.  From this collection of ticks, Dr. Parker sent a 
sample to a colleague working at the Rockefeller Institute named Hideyo Noguchi.  Dr. 
Noguchi subsequently isolated what he termed a “filter passing virus,” with agent 
descriptions that are similar to the Nine Mile Isolate (NMI) strain of C. burnetii [3].  He 
subsequently passed the strain in guinea pigs for several generatio s however later lost 
the strain during passage.  This has prevented the retroactive comparisons of the strain 
Noguchi isolated with subsequent isolates of C. burnetii NMI [2]. 
In the spring of 1935 RML scientist Gordon Davis, while studying the ecology of 
RMSF and Tularemia, collected ~200 D. andersoni ticks from Nine Mile Creek 




separate guinea pigs for a blood meal.  Monitoring the guinea pigs for several weeks, he 
found that two of the pigs remained afebrile, the third died, and the fourth developed a 
fever on the 12th day post tick feeding [4].  The febrile guinea pig was then used to 
sequentially infect other guinea pigs, each of which subsequently develop d a similar 
febrile illness [4]. 
In 1936, Herald R. Cox began working at RML and was assigned by Dr. Parker to 
work with Dr. Davis on characterizing the Nine Mile agent.  Dr.’s Cox and Davis 
together worked on the NMI strain for several years characterizing numerous facets of 
the agent including its pleomorphic form resembling a Rickettsia species and that it was 
“not a filterable virus in the recognized sense of the term” [5]. In his April 1938 monthly 
report to the NIH director Rolla E. Dyer, Dr. Cox stated that he had discovered how to 
cultivate the NMI Rickettsiae in embryonated eggs.  This report pr mpted Dr. Dyer to 
make a personal visit to RML to verify Dr. Cox’s claims [2].  Through a series of 
fortuitous events, Dr. Dyer became infected with a laboratory acquired NMI strain and 
subsequently linked the pathophysiology of the NMI agent to the Q fever agent 
simultaneously being worked on in Australia [6]. 
In 1935, the director general of the Heath Medical Services for Queensland, 
Australia, Sir Raphael Cilento, approached the Director of the Laboratory of 
Microbiology and Pathology of the Queensland Health Department at Brisbane – Edward 
H. Derrick M.D. – and charged him to investigate an outbreak of an unknown febrile 
illness in Brisbane abattoir workers [7].  Dr. Derrick began his studies into the Query (Q) 
fever agent by investigating clinical cases of Q fever, as they were manifested.  He 




being culture negative for common veterinary and zoonotic diseases of the region [7].  He 
suspected this disease to be caused by a novel agent.  This led him to attempt to isolate 
the agent by infecting guinea pigs with patient blood or urine samples.  These methods 
proved successful in producing the disease in guinea pigs, which he then used to begin a 
series of animal passages and studies in an attempt to identify the agent.  From his 
investigations, Dr. Derrick mistakenly concluded that the agent was viral and 
subsequently sent an emulsified saline liver sample to the noted virologist Macfarlane 
Burnet [7] at the Walter and Eliza Hall Institute [2] in Melbourne, Australia.   
Dr. Burnet and his colleague, Mavis Freeman, set out together to fur her 
characterize the Q fever agent received from Dr. Derrick.  Through subsequent filtration 
and serum agglutination experiments, they concluded that the agent was a new Rickettsial 
agent [8].  Dr. Burnet sequentially succeeded in characterizing the unique properties of 
this organism and its status as a unique species.  For this reason, Dr. Derrick proposed the 
name of Rickettsia burneti be applied to the Q fever agent [9]. 
Around the same time (1939), Dr. Cox proposed a name for the NMI agent to be 
Rickettsia diaporica (diaporica is Greek for having the ability to ‘pass through’, e.g., a 
filterable Rickettsia) [10].  It was not until 1948 that the classification and nomenclature 
of the Q fever/NMI agent was finalized.  Cornelius B. Philip of RML proposed that the 
current status of Coxiella (at the time being a subgenus of Rickettsia) be elevated to full 







COXIELLA BURNETII:  Q FEVER 
Q fever has two basic disease manifestations – acute nd chronic – which can range 
from sub-clinical having no recognizable symptoms, to physically debilitating such as 
endocarditis and in some cases even death [12].  The minimum infectious dose for human 
acquisition of Q fever typically ranges from 1 to 10 organisms [13].  The typical clinical 
manifestation of an acute Q fever case is characterized by a febrile illness lasting from 7 – 
57 days in untreated individuals [14].  This fever can be accompanied by one or all of the 
following:  a general feeling of malaise, chills, photophobia (light aversion), night sweats, 
and a general overall feeling of excess fatigue [6]. These symptoms are commonly 
associated with a host of bacterial and viral diseases, leading to frequent under or 
misdiagnosis of Q fever cases [15]. 
Chronic Q fever develops in susceptible individuals after an acute Q fever episode 
[16, 17].  It has been hypothesized that C. burnetii is never entirely cleared from an infected 
individual following an acute Q fever episode and thus poses a potential source of C. 
burnetii  for a chronic Q fever episode in susceptible individuals [16, 17].  Polymerase chain 
reaction (PCR) analysis has indicated the presence of C. burnetii DNA in the bone marrow 
of convalescent acute Q fever patients independent of chronic Q fever manifestations [16, 
17], suggesting the possibility of C. burnetii being sequestered in immunologically 
privileged sites [16, 17].  Until susceptible conditions arise within the convalescent 
individual, the conditions for Chronic Q fever manifestations remain at bay. 
Recently, a 13 year retrospective study evaluated 1,383 confirmed Q f ver cases 
[18].  Of these cases, 77% were found to have had the acute form of Q fever while 23% 




Acute patients, they were classified as with, 40% hepatitis, 20% pneumonia coupled with 
hepatitis, 17% pneumonia, 17% fever only, 1% meningoencephalitis, myocarditis or 
pericarditis – respectively, and 0.7% with meningitis only [18], with the remaining 2.3% 
remaining unclassified.  They found that 13 individuals who manifested with myocarditis 
or meningoencephalitis died [18], a rate of ~1% which is similar to the 1-2% of deaths 
typically associated with Q fever infections [12].  In this study, age and gender 
associations with acute Q fever revealed that hepatitis predominated in younger 
individuals.  Pneumonia was manifested mostly in the elderly and i 
immunocompromised patients, while female patients suffered mostly from isolated 
febrile symptoms.  These data indicate that there are likely many host factors that 
influence the clinical expression of acute Q fever [18].  Treatmn  for acute Q fever is 
usually with tetracycline, rifampin, doxycycline, quinolones, or macrolides for 7 - 10 
days [19, 20]. 
C. burnetii-induced endocarditis is of particular concern following an acute episode 
of Q fever.  After exposure, 40% of people with underlying heart valve defects or prosthetic 
valves will develop valvular Q fever endocarditis [21].   In many countries, Q fever 
infection of heart valves is a leading cause of culture negative endocarditis [22, 23]. 
Treatment for chronic Q fever endocarditis is costly.  Antibiotic courses of doxycycline and 
hydroxychloroquine for 18 - 24 months are often accompanied by surgical removal of the 
infected valve [24].  Relapse in the repaired valve or other valves of the heart is common 
[25] making this a particularly insidious chronic infection.  It has been suggested that this 
syndrome is considerably under-diagnosed [22] in culture negative endocarditis cases 




leading to endocarditis, a combination of doxycycline plus hydroxychloroquine has been 
shown to be a superior preventative treatment than doxycycline alone [21]. 
Immunologically privileged and/or poorly accessible immune system sites in the 
body are the locations where C. burnetii safely sequesters itself resulting in chronic Q 
fever.  Some of these locations include: 
• Heart valve tissues and the heart lining causing endocarditis and pericarditis [16, 
18, 21, 26-32] 
• Nervous system and brain resulting in meningitis and encephalitis [18, 33-35]  
• Osteoarticular regions causing bone infections [18, 36, 37] 
• Hepatic/liver causing hepatitis [38] 
• Placenta leading to fetal abortion, low birth weight  [18], infantile mortality [39], 
• Reproductive organs and tissue leading to possible infertility [40-42] 
Chronic Q fever is classically associated with clinical outcmes of endocarditis, hepatitis, 
and chronic fatigue syndrome [43, 44]. 
Clinical diagnosis of Q fever is determined by a rise in serological antibody titer to 
the C. burnetii phase II antigen for acute disease and an increase in antibodies to phase I 
antigen for the chronic form [45-47].  PCR and immunohistochemistry (IHC) have also 
been used to detect C. burnetii DNA and whole cell antigen, respectively, in histological 
samples [48].  Clinical confirmation of acute Q fever is based on serological evidence from 
Indirect Fluorescent Antibody (IFA) assays using phase II specific antigens.  Acute Q fever 
antibody titers of IgM >1:50 and IgG >1:200 dilutions of patient sera are considered positive 
[45-47].  For chronic Q fever, antibody titers to thephase I antigen of >1:800  and >1:50 for 




COXIELLA BURNETII:  VACCINE DEVELOPMENT 
Coxiella burnetii vaccination measures have been attempted for years with varied 
results [12].  Attempts to develop a large-scale, universally effective C. burnetii 
vaccination program has proven complex.  A key correlation exists between program 
design and application with respect to individual vaccine candidates’ p rsonal 
immunological history regarding previous exposure to C. burnetii [49].  Individuals 
previously exposed to the Q fever agent can result in adverse reactions to the vaccination 
that can range from local to systemic [49-51].  For this reason ny attempt to vaccinate 
individuals must include a prescreening process that detects and exclu es individuals 
with previous exposure to C. burnetii [49].  
Recently, monovalent phase I vaccines have proven effective against subsequent  
aerosol challenge models using mice [52], guinea pigs [51, 53] and monkeys [54].  
However, research also shows that C. burnetii has heterogenic antigenicity [55, 56] so a 
monovalent vaccine may not prove effective against all antigenic forms f C. burnetii 
[12]. 
Though the total effectiveness of monovalent vaccines has yet to be fully assessed 
against heterogenic C. burnetii exposures, a commercially available Australian licensed 
vaccine, Q-Vax, has had favorable results among human volunteers in Australia [54, 57, 
58].  Recent work on selection of specific immunodominant antigens and their 
effectiveness for inducing an immunological reaction providing immunity to C. burnetii 
are in the animal model phase [59, 60].  Should this approach be found efficacious, it 





COXIELLA BURNETII:  EPIDEMIOLOGY 
Reservoirs for C. burnetii vary widely.  C. burnetii has been demonstrated to 
infect livestock and wildlife [61-68], pets [69, 70], birds [68, 71-74], ticks [27, 75], 
arthropods [12, 76], poikilotherms [68], and amoeba [77].  In the United States, he 
seroprevalence rates among goat, sheep, and cattle, re 41.6%, 16.5%, and 3.4% 
respectively [78].   Sheep are the most commonly report d source for human infection [78].  
Chronically infected animals shed bacteria in milk and urine [79-81].  Though it does not 
commonly present itself as an overt disease in goats, sheep, and cattle, C. burnetii has a 
tropism for placental/birthing tissues and causes many spontaneous abortions [82, 83].  
Birthing materials (placenta, amniotic fluids) have been shown to harbor on the order of 109 
organisms per gram [67] that can be aerosolized and infect other animals or people upon 
parturition. 
Domesticated animals present a means by which the animal and human worlds 
conjoin for C. burnetii infections.  A particularly interesting demonstration of this involved a 
pet cat infected with C. burnetii delivering kittens in a basement near a group of poker 
players, resulting in exposure and infection of the players resulting in an urban outbreak of 
C. burnetii pneumonia [84].  A seroprevalence study using PCR and IFA screening methods 
to detect C. burnetii infected domestic and feral cats in Korea and Japan found a 
significantly higher C. burnetii infection rate among feral cats (41.7% versus 14.2% in 
domesticated cats) [85].  Another study of anti-C. burnetii phase II antibody seroprevalence 
in wild brown rats from various United Kingdom locations found anywhere from 7% to 
53% of rats were phase II seropositive [86], suggestive of a potential link between a wild 




A vast array of domestic and wild birds have been shown to harbor C. burnetii 
including poultry (chicken, turkey, geese, and duck) [67], quail and doves [72], crows 
[68, 71, 72], sparrows [68, 71], pigeons [68, 71, 73], owls, swallows, and parrots [68].  
Birds pose a potential source for zoonotic infection of humans by inhalation of 
contaminated fomite bird products [12].  In summary, reservoirs for potential zoonotic 
transmission of the Q fever agent are plentiful in both natural and domestic environments. 
 
COXIELLA BURNETII:  GLOBAL DISTRIBUTION 
The global distribution of C. burnetii has been firmly established [67] with the 
notable exception of New Zealand [12, 87, 88].  Various searches have been undertaken 
in New Zealand, but none have found any evidence for the presence of C. burnetii [12, 
88].  One 1993 study looked at 2,181 bovines and 12,556 canines with recent histories of 
fetal abortions (a likely indicator of C. burnetii infection).  Negative results were 
obtained for the Q fever agent in all animals tested [88]. 
New Zealand has been given the moniker of the “land of birds.”  This has 
reference to the faunal record of the islands.  The absence of nonvolant terrestrial 
(mammalian) fauna prior to the habitation of the original Maori settlers (c1300 A.D.) is 
well documented [89].  Given the fowl and faunal history of the island country, the 
conspicuous absence of C. burnetii from New Zealand is baffling when one considers 
two factors, namely migrating fowl returning to the island from distal C. burnetii 
endemic locations, and the importation of livestock (in particular sheep, cattle, and goats) 
from C. burnetii endemic regions such as neighboring Australia.  At least one of these 




Though these routes for C. burnetii infection of New Zealand are distinct possibilities, 
the 1993 study strongly suggests that these have not occurred. 
Conversely, the Canary Islands are highly endemic for C. burnetii.  A recent 
eleven year study found that among a group of patients with community-acquired 
pneumonia (CAP), a subset (28%) where found to have a pathogenic source of the 
disease.  Of these 28% CAP cases, it was found that C. burnetii was the most common 
source (20.1%) as compared to other sources such as Streptococcus pneumonia (16.6%), 
Mycoplasma pneumonia (15%), Chlamydophila pneumonia (13.4%), and Legionella sp 
(8.7%) [90].  Interestingly, Norway remained Q fever free until 1997 when four 
Norwegian tourists returned from travel to Bhutan, the Canary Island , and Morocco.  
Upon reentry to Norway, each presented with acute Q fever [91]. 
Given the ease and speed of modern travel, it is likely only a matter of ime until 
the first case of Q fever will be found in New Zealand.  Once this occurs, all major areas 
of the globe will have confirmed C. burnetii or Q fever cases. 
 
COXIELLA BURNETII:  TRANSMISSION 
Aerosol transmission of Coxiella burnetii is the primary mode of human acquired 
Q fever.  C. burnetii aerosols are typically generated as contaminated dust from soils 
becomes disturbed and airborne [66, 92].  Fomite C. burnetii aerosols are generated in 
zoological associated activities such as animal processing at abattoirs [93, 94] and the 
birthing of chronically infected livestock which typically exposes veterinarians [69, 95-
98] and animal handlers [78] to Coxiellae.  Actively growing C. burnetii in laboratory 




highlights the infectivity of C. burnetii via aerosolization was reported at a medical 
school in which pregnant sheep were being used for perinatal research.  Unknown to 
researchers and the animal handling staff, certain of the pregnant sheep were infected and 
actively shedding virulent C. burnetii.  When the first cases from this facility were 
diagnosed and reported, a wider investigation ensued.  In total, 137 individuals tested 
seropositive for phase II C. burnetii antigen.  Of the seropositive individuals, 41 had been 
directly involved with the sheep while the remaining 96 were located long sheep carting 
routes throughout the facility from the animal housing area to the research labs [99]. 
Ingestion of C. burnetii contaminated materials is a second mode of bacterial 
transmission, though in relation to aerosols this is a far less common.  The shedding of C. 
burnetii in milk [55, 63, 100-102] has led to cases of Q fever [103].  C. burnetii shed via 
urine and fecal material [12] and runoff under unsanitary conditions can present a 
potential fecal-oral infectious route from contaminated water store .  The transmission of 
C. burnetii via fecal-oral and aerosol mechanisms between livestock is likely considering 
the relative proximity of living conditions in feedlots, stockyards, and barns.  It has been 
speculated that C. burnetii infection via ingestion may present a primary mode for hepatic 
Q fever [12, 103]. 
Arthropod/Vector borne transmission of the Q fever agent to humans via tick bite 
is rarely reported in the literature [12].  Recognizing that C. burnetii was initially isolated 
and identified via D. andersoni ticks [4], only a select few instances of tick vectored 
human Q fever cases have been reported in literature [27, 75].  Historically it was thought 
that C. burnetii cycled in ticks via transovarial and transstadial transmission [104, 105] 




Venereal transmission of C. burnetii has been demonstrated in animal models 
[106].  In 2001, a single case was reported of a man who had acquired Q fever via an 
occupational exposure and subsequently passed it to his wife via intercours  [107].  This 
method of transmission is rare but possible with individuals shown to have C. burnetii in 
their reproductive tissues as was the case in this report [107]. 
Cutaneous transmission of C. burnetii was suggested in a 1993 report [108].  This 
report, though not definitive, does present the possibility that a cutaneous i fection of C. 
burnetii may be possible; however, it remains an extremely unlikely route for obtaining Q 
fever. 
 
COXIELLA BURNETII:  BIO-WEAPON? 
The potential of biological agents for use in bio-weapons development ar 
typically measured against specific criteria.  These include the ability to disable troops 
and/or civilians, potential for mass production, ability to be adapted to a viable delivery 
system (e.g., aerosolizable), and long term environmental viability [109].  Considering 
these criteria C. burnetii is suitable for development as a biological weapon; however, 
militarily it is only considered a disabling weapon do to its lack of a high mortality rate as 
compared to other agents such as B cillus anthracis [13]. 
The United States and the former Soviet Union are both suspected of having 
researched and/or weaponized C. burnetii [109].  Evidence for its use during armed 
conflicts is speculative, though several instances of confirmed outbreaks of Q fever 
amongst soldiers during World War II exits.  However, the majority of these outbreaks 




States government did list C. burnetii amongst agents for biological weapons 
development in 1942 at the biological program at Fort Detrick, MD [109].  In 1954 
project “Whitecoat” was carried out by exposing human volunteers to aer sol releases of 
C. burnetii [113]. 
Recent evidence shows that the cult Aum Shinrinkyo, famous for its March 1995 
sarin gas attack on the Tokyo subway system was developing C. burnetii for bio-
terrorism when it was discovered and disbanded [114].  Various theoreical biological 
attack scenarios, each modeling C. burnetii have been proposed in the literature 
illustrating the potential threat and possible consequences of a succes f l Q fever attack 
[109, 115]. 
 
COXIELLA BURNETII:  SELECT AGENT STATUS 
The United States Select Agent Program fulfills legislative requirements as set 
apart in the USA PATRIOT Act of 2001 and the Public Health Security and Bioterrorism 
Preparedness and Response Act of 2002 regarding dangerous biological agents and 
toxins.  The Select Agent Program unconditionally restricts the unauthorized 
manipulation of designated agents categorized as potential biological weapons candidates 
[116].  For each candidate agent on the Select Agent list, specific laboratory and 
personnel approval must be obtained in order to maintain, manipulate, or perfm 
research on the specified agent.  This approval comes directly from the designated 
responsible agency that has been assigned overseer responsibility for each specific Select 
Agent.  All C. burnetii strains with the sole exception of C. burnetii Nine Mile phase II 




under the Select Agent Program, is overseen by the CDC, and are categorized as category 
“B” Select Agents [118].  C. burnetii has been categorized as a category “B” select agent 
by the United States government because it lacks the potential for massive fatalities that 
category “A” Select Agents do (e.g., Bacillus anthracis, Francisella tularensis, and the 
Smallpox virus) [116, 118]. 
 
COXIELLA BURNETII:  BIOLOGY 
Taxonomic characterization of C. burnetii is of the Kingdom: Bacteria, Phylum: 
Proteobacteria, Class: γ-Proteobacteria, Order: Legionellales, and Family: Coxiellacae.  
C. burnetii is an obligate intracellular, Gram-negative rod that exhibits pleomorphic 
characteristics having a distinct poly-phasic life cycle generalized to correspond to stages 
inside and outside of the host cell [119]. 
Morphologically distinct forms of C. burnetii have been documented in the 
literature from as early as 1959 when B. Babudieri reported his light microscopy 
observations of “a very short rod, frequently with a bipolar appearance and sometimes as 
a minute paired coccus” [67].  Later following electron microscopy bservations of C. 
burnetii, he erroneously concluded that “[C. burnetii] shows a marked uniformity of 
dimensions, which shows that the various appearances seen under the optical microscope 
are due more to differences in dye affinity than to morphologic variations” [67].  The true 
morphological status of C. burnetii was debated until 1981 when transmission electron 
microscopy (TEM) showed C. burnetii as having distinct forms termed large cell variants 
(LCV), small cell variants (SCV), and spore-like particles (SLP).  The approximate sizes 




SLP varying from 0.13 – 0.17µm [120-122].  Further characterization of the SCV form 
were made to designate what is called the small dense cell (SDC) form of SCVs.  The 
SDC subset has been shown to resist pressures up to 20,000 lb/in2 which kills the typical 
SCVs [123].  Though TEM evidence exists for these SDC and SLP forms, it remains 
difficult to separate these to purity from the dominant LCV and SCV forms of C. 
burnetii.  Considering this limiting fact, the current body of work differentiating the 
biological forms of SDC and/or SLP is largely hypothetical and has not been tested in-
depth; therefore, the role they play in infectivity, disease, and cell survival of C. burnetii 
is unknown [122]. 
The LCV is considered to be the metabolically active form of the bacterium [120], 
whereas the SCV and SDC are environmentally stable, metabolically inactive forms of C. 
burnetii [119].  The differences in the LCV and SCV forms of C. burnetii can be likened 
to log-phase and stationary phase growth states of other bacteria, respectively [122].  The 
different physical states of the LCV and SCV can be characterized by shifts in size, 
membrane structure, and proteome expression.  For example, the major outer membrane 
protein (MOMP) of C. burnetii, designated P1 (~29kDa), is highly expressed in the LCV, 
down-regulated in the SCV, and absent in the SDC [119].  Studies have s own that 
peptidoglycan (PG) levels shift as the bacteria changes from SCV to LCV and back to the 
SCV form.  The composition of the peptidoglycan protein complex (PG-PC) of the C. 
burnetii cell wall structure has been shown to be ~2% PG-PC in the LCV, whereas the 
PG-PC of the SCV is ~32% [124].  It has been hypothesized that partial enzymatic 
digestion of the SCV PG wall or a possible incomplete synthesis of PG occurs in the 




The differing PG-PC content of the cell wall of the LCV verses the SCV forms, 
the ultra-structural nucleoid of C. burnetii exhibits a marked variation that differentiates 
these forms.  The SCV expresses a histone-like protein designated Hq1 that displays 
compositional and primary amino acid similarities to the eukaryotic histone H1 homolog 
[125].  The Hq1 protein is absent (or drastically reduced) in the LCV form of C. burnetii 
[125].  In addition, a small basic protein solely translated in the SCV (designated ScvA), 
was discovered to have a function analogous to the Hq1 protein [126].  The presence of 
DNA condensing histone-like proteins in the SCV is logical given its spore-like nature, 
diminished size, and small electron dense morphology.  Recently an in-depth proteomic 
study of protein/antigen variations expressed in LCVs and SCVs identif ed a number of 
form-specific proteins [127].  Using CsCl2 differential centrifugation to separate LCVs 
from SCVs coupled with 2D gel electrophoresis and mass spectrometry, a series of 
differentially expressed proteins were identified, 15 in the LCV and 4 in the SCV.  
Functional roles associated with these expressed proteins were found to be correlate with 
the metabolically active LCV and structurally stable SCV forms [127]. 
Both LCV and SCV forms have been shown to be infectious in vitro [122, 128]; 
however, the SCV is widely considered to be the primary infectious f rm of the 
bacterium in natural environments as it is likely the form responsible for extracellular 
survival of the bacterium in the environment [122].  The LCV is considered to be the 
metabolically active and primary host cell-to-cell spreading of the infectious form of C. 
burnetii in vitro and presumably in vivo, although it is environmentally unstable [122].  
Recently the cell cycle kinetics of C. burnetii infection in vitro were thoroughly 




that defined lag, log and stationary phases of C. burnetii growth exist [127, 129].  The 
SCV form of the bacterium predominates during the first 2 days post infection (PI) as 
SCV to LCV morphogenesis occurred (analogous to a lag phase).  From day 2 to day 6 
PI, the LCV form was found exclusively within infected cells and exponential replication 
occurred (exponential phase).  After day 6 PI, both LCVs and SCVs were shown to exist 
in cells as LCV to SCV reversion began to occur (stationary phase) [127, 129].  
Extracellular signals presumably effect this biphasic conversion of C. burnetii forms, yet 
the cellular signals and bacterial mechanisms involved remain relatively unknown [122]. 
SCV and LCV forms of C. burnetii each play pivotal roles in the infectious life 
cycle.  Conversion from SCV to LCV and back to SCV forms occurs, allowing C. 
burnetii to maintain its ability to be environmentally stabile in the SCV form, while 
intracellular conversion to the LCV provides for its metabolic necessiti s and replication.  
It is then shed into the environment as the SCV form where it will reside until it is passed 
to a new host and reinitiates its infectious cycle [122]. 
 
COXIELLA BURNETII:  ENVIRONMENTAL STABILITY 
Environmental stability of C. burnetii SCV has been demonstrated under various 
chemical and radiation sterilization methods.  Chemical and physical treatments of C. 
burnetii using methods which sterilize most bacteria (including Bacillus spores) show 
little effect on Coxiellae [130, 131].  Additionally C. burnetii shows resistance to UV, 
desiccation, osmotic shock, sonication (in distilled H2O >30 min.) and elevated 
temperatures (63°C for 30 min.) [122, 130].  Following 24 h treatments with 0.5% 




still detectable while Bacillus spores were inactivated under the same conditions [130].  
However, 70% ethanol, 5% chloroform, or 5% Enviro-Chem have been shown to be 
effective in inactivating C. burnetii with 30 min of treatment [130].  These results have 
led researchers to speculate that the environmental stability of C. burnetii is related to the 
“sporulation process” which produces the SCV and SDC forms [130]. 
The minimum dose of gamma irradiation required to inactivate 90% of C. burnetii 
Phase I and II under stabilizing conditions (-79°C in blended yolk sack membranes) has 
also been determined.  Depending on the phase of C. burnetii, the 90% inactivation 
values are 0.64 and 1.2 kGy (kilogray units) for Phase I and Phase II, respectively [131].  
In all samples, viable C. burnetii were found following a 5 kGy dose; however, following 
a 10 kGy dose no retrievable viable C. burnetii was found [131].  Of interest, it was 
found that gamma irradiation up to 20 kGy had no demonstrated effect on cell-wall 
morphology or surface antigenic epitopes of the cells as compared to non-gamma 
irradiated C. burnetii cells [131]. 
 
INTRACELLULAR GENETICS 
Genetic manipulation of bacteria is a cornerstone of modern molecular pathogenesis 
research; however, developing genetic systems for the obligate intracellular bacteria has 
remained particularly difficult.  Foreign DNA can be introduced into C. burnetii by 
electroporation [132-134], yet propagation of clona isolates has, until recently, proved 
elusive.  Only recently it was reported in the litera ure that a stable isolate of a C. burnetii 
ftsZ (transposon disrupted) mutant was isolated.  The genetic manipulation was 




the mCherry fluorescence protein with a chloramphenicol antibiotic resistance gene [134].  
As the ability to site specifically mutate the C. burnetii genome develops, it should led to an 
accelerated understanding of critical components of he genetic systems of C. burnetii. 
The Coxiella burnetii Genome:  Pulse field gel electrophoresis restriction 
fragment studies estimated the full-length C. burnetii genome size to be between 1.6 – 
2.1 x 106 base pairs [135, 136].  The complete genome sequence of the C. burnetii NMI 
RSA493 isolate was published in 2003 [137].  The genome sequence reveal d its size to be 
1,995,275 base pairs with a 42.6% GC content.  The genome is predicted to encode 2,094 
open reading frames (ORFs), of which 1,022 show homol gy to known genes [137].  
Approximately 45% of the predicted encoded proteins have a pI greater than 9.0 making a 
large portion of C. burnetii protein’s content very basic.  The basic nature of these proteins 
has been hypothesized to function as a “proton sink,” buffering C. burnetii from excess H+ 
ions found in the phagolysosome environment [137]. 
The genome sequence also revealed 83 pseudogenes and 32 insertion sequence (IS) 
elements, 21 of these being copies of the same IS1111 element [137].  Sequence analysis 
also revealed C. burnetii genes associated with adhesion and invasion (13 ankyrin repeat-
containing proteins), intracellular trafficking, detoxification mechanisms (multi-drug 
efflux pumps), and host-cell modulation mechanisms (Type I, II, and IVB secretions 
systems) [137].  The lifestyle of C. burnetii highly resembles Rickettsiae and Chlamydiae 
bacteria; however, the genome sequence is decidedly different from these other 
intracellular bacteria species.  In fact, the genome content indicates that the obligate 




Antibiotic Resistance in bacterial pathogens, particularly a bio-threat organism 
like C. burnetii, is concerning.  The current antibiotic groups used for treating acute and 
chronic forms of Q fever include the tetracyclines, rifamycins, quinolones and macrolides 
[19].  However, studies show varying efficacy effects with these antibiotic groups [138].  
Although, some data indicate the presence of doxycycline resistant strains emerging in 
humans and animals [139].  Evidence exists that suggests the ability of individual C. 
burnetii strains to produce acute vs. chronic disease may have a direct co relation to the 
bacterium’s antibiotic resistance capabilities [140].  The genome sequence of the NMI 
isolate revealed that it contains a high proportion of multi-drug efflux pumps (MDEP) per 
mega-base of genome sequence (~11 MDEP/Mbase).  More than 25% of the transporters 
encoded in the NMI genome are predicted to be MDEPs.  The high proportion f MDEPs 
encoded by the NMI genome exceeds those of all other known Proteobacteria bacteria 
[137].  It is speculated that this high proportion of MDEPs in the NMI genome may be 
related to the harsh environment of the phagolysosomal environment that C. burnetii 
inhabits, and that these MDEPs are used to shuttle host cell defensive measures (defensins, 
etc) out of the bacterial cell [137]. 
Rickettsiella grylli:  Taxonomic and phylogenetic studies of Rickettsiella grylli 
have shown it to be the closest relative of C. burnetii [141, 142].  R. grylli is an 
intracellular parasite of arthropods such as grasshoppers [141] and crickets [142].  It has a 
bi-phasic life cycle akin to the Chlamydial reticulate and elem ntary body forms [143, 
144].  Murine infection studies using R. grylli demonstrated a lack of cytological, 
serological, or electron microscopic effects [145].  Evidence shows that R. grylli 




Genetically the genome for Rickettsiella grylli has been shown to be ~2.1 mega base in 
size [147] roughly 1kb larger than the C. burnetii genome.  Efforts are underway to 
sequence the full genome of R. grylli to look for possible clues into core genetic features 
common between R. grylli and C. burnetii [141]. 
Legionella pneumophila:  Morphological distinctions of C. burnetii and its 
“Rickettsial-like” nature have historically categorized C. burnetii amongst the Rickettsial 
species of bacteria [137].  16S rRNA gene sequencing analysis [148] coupled with 
protein and phylogenetic analysis of conserved proteins [137] demonstrated C. burnetii to 
be closely related to Legionella pneumophila.  Subsequently, C. burnetii was re-
categorized as a member of the Proteobacteria, order Legionellales.  L. pneumophila is a 
facultatively intracellular bacterium that exhibits a life cycle akin to, yet distinct from that 
of C. burnetii.  L. pneumophila lives inside a specialized phagosome yet it actively 
prevents lysosomal fusion [149] whereas C. burnetii requires lysosomal fusion to occur 
to develop a mature phagolysosome.  The published genome sequence of L. pneumophila 
indicated a total genome size of ~3.4 Mbp.  Surprisingly, ~42% of the L. pneumophila 
genes have homology to the C. burnetii genome despite Coxiella’s reduced genome size 
of ~1.9 Mbp [150]. 
Coxiella burnetii plasmids:  Four plasmids have been found associated with C. 
burnetii.  C. burnetii isolates contain one of four basic plasmid types; QpH1, QpRS, QpDV, 
or QpDG [151] at a relatively low copy number (1-5) [152].  The QpH1 plasmid found in 
the NMI strain is comprised of 37,393 base pairs that encode 40 predicted ORF’s [152].  It 




either an acute or chronic disease [153]; however, this remains a debate within the field 
[154, 155]. 
 
COXIELLA BURNETII:  PHASE VARIATION 
The phase variants of C. burnetii LPS have been likened to the classic smooth vs. 
rough LPS of enteric gram negative bacteria, with phase II LPS being equivalent to the 
rough form while phase I is equivalent to the smooth virulent form [156].  With 
continued in vitro passage of phase I C. burnetii, it has been demonstrated that overtime 
the virulent phase I LPS shifts to a truncated, avirulent phase II form [156]. 
A study on the DNA of phase I C. burnetii Nine Mile Clone 7 (NMI) and phase II 
C. burnetii Nine Mile Clone 4 (NMII) strains using restriction endonuclease digestion 
concluded that the isolates differed genetically (as clonal isolates) but did not in show 
antigenic phase variation [157].  Results from restriction fragment length polymorphism 
studies using HaeIII digestion of genomic DNA from NMI and NMII strains showed the 
absence of one HaeIII fragment from NMII in the comparative patterns.  Additionally, a 
comparison of the NMII strain (which does not survive animal passage) to the C. burnetii 
Grita M44 phase II strain (which is capable of passage in animal models) showed the 
presence of the missing HaeIII fragment in the Grita M44 phase II strain.  These data 
suggest that the HaeIII fragment contains information needed to allow survival of the 
NMII in vivo [158]. 
Comparisons of cosmid clones derived from C. burnetii NMI and C. burnetii 
NMII strains have shown an 18 kb deletion in the genome of C. burnetii NMII [159].  In 




C. burnetii Nine Mile RSA514 Crazy strain (Crazy Q), non-virulent NMII, and the 
virulent NMI.  This showed a 29 kb deletion in Crazy Q that overlapped th  18 kb 
fragment also deleted in NMII strain.  The deletion of both strains showed had a common 
terminus.  This indicated that the Crazy Q included an additional 11 kb deletion 
immediately upstream of the common 18kb deletion for these strains [159].  This remains 
interesting as Crazy Q remains moderately virulent, while NMII does not, despite the fact 
that they each miss the same 18 kb fragment.  This may indicate som  importance for the 
additional 11kb deletion in the Crazy Q strain verses the common 18kb deletion. 
The lipopolysaccharide (LPS) molecule of the C. burnetii gram negative cell wall 
has been shown to be a virulence factor [155] directly associated with the severity of Q 
fever disease [160].  Three LPS structural variants have been identified in different C. 
burnetii phase variants [161, 162].  The three LPS forms have been shown to correspond 
to the antigenicity of their respective phase variant [160].  C. burnetii with phase I LPS is 
highly infectious causing seroconversion and Q fever in the host with bac erial recovery 
from the host cell 30 days PI [160].  Although phase II C. burnetii strains are 10 times 
more infectious than phase I strains in cell culture models [160], phase II C. burnetii  
lacks the ability to cause Q fever associated symptoms in animal models and cannot be 
recovered from animals at 30 days PI [160].  This same study tested the virulence from 
the Crazy Q strain of C. burnetii.  Which showed high infectivity with moderate Q fever 
symptoms in animal hosts, but it was not  recoverable 30 days PI [160]. 
Recent size exclusion chromatography experiments on phase I LPS have shown 
that the O-polysaccharide affects the antigenic reactivity.  Methylation linkage analysis 




sugars.  Serological evidence implicates virenose and dihydrohydroxystreptose as key 
glycan antigens involved in the immunobiology of Q fever pathogenesis [163].  The lipid 
A portion of the LPS of both phase I and phase II has been shown to be identical [164]. 
The avirulent phase II LPS has been shown to have a genomic deletion linked to 
the previously described 18 kb deletion [159].  The O-antigen biosynthesis g ne cluster 
was shown to be contained within this 18 kb deleted span [165].  The absence of the O-
antigen gene cluster presumably results in the attenuated phenotype of the phase II LPS 
molecule [160, 165].  This common 18 kb deletion of Crazy Q [159] suggests a simil r 
phenotype; however, Crazy Q maintains a medium length LPS and remains oderately 
virulent in vivo. 
The virulence differences between the three LPS variants relateto the shielding 
effect provided by full-length C. burnetii LPS as opposed to truncated LPS forms [166].  
Studies using C. burnetii NMI Phase I verses C. burnetii NMII Phase II treated human 
dendritic cells (DC) demonstrated that the NMI strain (having full length LPS) prevented 
DC maturation, allowing C. burnetii NMI infections to persist.  However, DC infections 
with the NMII strain resulted in DC toll-like receptor (TLR) 4-independent maturation 
with production of interleukin-12 and tumor necrosis factor.  Additionally it was shown 
that NMI LPS did not fundamentally alter the ability of the DC cells to mature as 
subsequent application using purified E. coli LPS, or the combination of a super-infection 
with NMI infected DCs subsequently infected with NMII, resulted in DC maturation in 
each instance.  Subsequent tests using NMI LPS-minus cells were shown to be infectious 
in DCs; however, these cells were unable to prevent DC maturation [166].  These results 




preventing maturation thereby allowing the C. burnetii bacterium to persist within the DC 
[166]. 
 
COXIELLA BURNETII NTRACELLULAR PATHWAY 
Obligate intracellular bacteria occupy a unique niche in the microbial world.  
Their survival and replication strategies could be compared, in a rudimentary sense, to 
that of viruses.  Like viruses, intracellular bacteria establish themselves inside and 
replicate within a host cell employing a parasitic strategy in the attempt to circumvent the 
host’s immune system by existing in a protected intracellular environment [167].  Some 
bacteria that have been shown to inhabit intracellular niches include, Rickettsiae, 
Chlamydiae, Ehrlichiae, Legionellae and Coxiellae species of bacteria.  Each of these 
intracellular bacteria utilizes an alternative intracellular strategy for replication. 
Rickettsiae species exhibit an “in and out” strategy of intracellular parasitism as 
they enter the cell via endocytosis and immediately leave the endocytic vesicle 
environment to replicate in the cytoplasm [168].  Chlamydiae, Ehrlichiae, and 
Legionellae are found in early endosomal, mid to late endosomal, and late endosomal 
intracellular sites, respectively.  They enter cells via endocytosis and then subvert the 
endosomal pathway where they replicate in these unique environments [168]. Only the 
C. burnetii resides in a compartment which appears to resemble a completely mature 
phagolysosome [168, 169].  It is in this harshest of intracellular environments that C. 
burnetii survives and replicates.  During a naturally acquired infection (via aerosol), C. 
burnetii initially targeted by alveolar macrophages upon entry to the host lung.  Once inside 




tissues [122].  Once C. burnetii has been shuttled into the acidified phagolysosomal vacuole 
of the host cell [155], the C. burnetii containing compartment is referred to as a 
parasitophorous vacuole (PV).  It is here that the organism lives and replicates with a 10 – 
12 hour doubling time in exponential phase [129, 170]. 
The C. burnetii uptake/internalization process by the host cell occurs via a 
microfilament dependent endocytosis mechanism [171].  In human monocyte THP-1 
cells it has been shown that attachment of C. burnetii NMI induces protein tyrosine 
kinase activities that result in phosphorylation of tyrosine residues on host proteins 
including Src-related kinases, Hck and Lyn, that co-localize to the F-actin cytoskeleton.  
This activity results in the reorganization of F-actin [172] causing pronounced membrane 
protrusions at theTHP-1/NMI interface within 5 minutes of interaction which are no 
longer visible by 60 minutes PI [173].  Conversely, this activity does not occur with the 
avirulent NMII strain despite its ability to be more efficiently endocytosed [173].  This 
may be attributed to the truncated LPS of NMII making the bacterium highly 
hydrophobic [174] which may increase the probability that non-specific hydrophobic 
interactions between pathogen and host cell, thus increasing NMII’s likelihood for uptake 
[171].  Pretreatment of L cells with proteases (pronase, subtilisin or subtilopeptidase A) 
prior to infection with C. burnetii drastically inhibits bacterial attachment reducing 
cellular uptake, suggesting the involvement of a host cell surface exposed protein in the 
C. burnetii endocytic process [171]. 
Possible host binding domains include complement receptor 3 (CR3) and TLR4.  
Uptake of C. burnetii was investigated using a series of CR3 knockout experiments in 




extensions for C. burnetii uptake to occur.  Another study indicated that the uptake of 
virulent Phase I C. burnetii is dependent on TLR4 in macrophages through an interaction 
with the LPS.  This activity was not seen with Phase II variants of C. burnetii [176].  Of 
particular interest in this study was that they were able to demonstrate that TLR4 had a 
role in the induction of F-actin rearrangement in macrophages; however, the TLR4 did 
not have any effect on phagosomal maturation or macrophage microbicidal activity on C. 
burnetii as TLR4 (-/-) mutants showed no deviation from the wild-type in the 
intracellular fate of the bacterium once uptake had occurred [176].  Even in knockouts of 
the possible host ligands, significant numbers of cells become infected [175, 176] 
indicating that multiple routes of entry are likely used by the pathogen. 
Though the story of C. burnetii uptake is beginning to be understood, there is 
currently little data regarding the specific bacterial and host cell receptor mediated 
ligand(s) required for C. burnetii uptake.  Given the variety of hosts C. burnetii is capable 
of infecting, it is unlikely that the organism requires a host specific mechanism to 
mediated cellular invasion.  It is likely that C. burnetii passively allows the host to 
internalize it by phagocytosis.  Once C. burnetii is internalized into a phagosome, it 
begins to manipulate this compartment.  The host cell protease treatment experiment 
previously described do seem to suggest at least some role for C. bu netii interaction with 
a host cell surface protein; however, it remains to be determined wh ther this is an active 
or passive interaction between ligand(s). 
Upon internalization, the C. burnetii containing vacuole begins to follow the 
standard endocytic pathway to lysosomal fusion [169], eventually acquiring the attributes 




approximately two hours [177].  Recent publications indicate that during th s two hour 
delay, the C. burnetii [178] PV interacts with the autophagy pathway, the PV membrane 
becoming decorated with the autophagosomal marker LC3 as early as five minutes PI 
[179, 180].  The autophagy data are beginning to shed light on some of the specific 
activities occurring during this two hour delay [127].  The mature PV membrane 
eventually co-localizes with cathepsin D (peptidase) [181], lysosomal-associated 
membrane glycoproteins 1 and 2 (LAMP1 and LAMP2) [169], 5’-nucleotidase (nucleic 
acid hydrolytic enzyme) [182], Rab7 (small GTPase and late endosomal marker) [180], 
and acid phosphatase (lysosomal phosphatase) [183].  Once the PV has fused with the
lysosome the PV becomes acidified to a pH of ~4.8 [184]. 
pH levels within the PV appear to play a vital role in the metabolic processes of 
C. burnetii.  The proton motive force generated as the PV acidifies creates an electron 
gradient across the membrane of C. burnetii that is harvested as fuel for its metabolic 
activities [185].  An in vitro cell free model system has been used to investigate C. 
burnetii’s metabolic activity [168, 184].  When comparing the metabolism of glucose and 
glutamate using the cell-free acid activation model, C. burnetii metabolism was highest at 
a pH of ~4.7-4.8 as compared to neutral (7.0 pH) or slightly alkaline pHs.  In fact, neutral 
or slightly alkaline pHs actually abolish C. burnetii metabolism [184].  These results have 
led to speculation that the conservation of metabolic energy at neutral or slightly alkaline 
pH contributes to extracellular survival of the organism [185, 186] in the SCV form. 
Once C. burnetii enters the host cell it is clear that it begins to have an effect on 
the fate of the endosomal compartment.  As early as five minutes post entry into the host 




with the autophagy pathway [179, 180].  Recently two studies demonstrated he essential 
role of de novo protein synthesis that affects maturation of the PV and its enlargement.  
Using bacteriostatic concentrations of either chloramphenicol (protein synthesis inhibitor) 
or carbenicillin (cell wall synthesis inhibitor), it was shown that active metabolic activity 
was required for proper C. burnetii trafficking within the host [187].  The 
chloramphenicol treated cells contained a series of individual tightly bound small LAMP-
1 positive PVs each containing single C. burnetii cells dispersed throughout the host cell 
cytoplasm [187].  Conversely, it was shown within the carbenicillin treated cells that 
mature large spacious PVs formed with multiple non-replicating C. burnetii therein 
[187].  Subsequent removal of chloramphenicol treatment showed vacuoles fused 
forming large spacious PV’s with multiple C. burnetii cells [188].  Additional 
chloramphenicol experiments using C. burnetii infected cells combined with the addition 
of latex beads were performed showing subsequent to chloramphenicol removal that the 
C. burnetii PVs fused with PVs containing latex beads.  Suggesting that active C. burnetii 
specific protein synthesis was critical for PV fusion within the host cell [188].  This has 
led to the idea that directed vesicular recruitment by C. burnetii is a primary means 
whereby Coxiellae obtain metabolites and nutrients as precursors for cellular metabolism 
[122].  Though the interactions involved in the autophagy and PV maturation/recruitment 
processes remain unknown at present, it is very likely that C. burnetii is directing the fate 






Bacteria live and interact with their varied environments via a host of diverse 
systems that are essential for their survival including, quorum sensing and conjugation 
systems, antibiotic and toxin release mechanisms, as well as motility and chemotaxis 
mechanisms.  These systems involve precise sensory response machinery that allows 
bacteria to detect and react to external and internal vironmental signals.  Of particular 
interest are bacterial secretion systems used to manipul te bacterial surroundings by 
emitting effector molecules via secretary machinery.  Secretion systems such as the type I 
and type II secretion systems have been shown to be relatively universal in bacteria and 
have been shown to perform a variety of functions related to cellular housekeeping activities 
[189, 190], while virulence associated functions have been attributed to the type III secretion 
system [191, 192]. 
Bacterial conjugation is a method used to shuttle genetic material among 
neighboring populations of bacteria.  Work has shown a variety of plant and animal 
pathogens using evolutionarily related conjugation systems as a means to deliver various 
effector molecules [193].  All ancestrally related conjugation machines used to mediate 
DNA or protein translocation are categorized as Type IV Secretion Systems (T4SS) 
[194].  As such, this definition is inclusive for all Gram-negative and Gram-positive 
bacterial DNA translocation machinery with genetic homology to conjugal machinery 
[195].  The T4SS is similar to the T3SS in that pathogens with a variety of lifestyles appear 
to possess it [196-198] and may deliver conjugated nucleoprotein and/or protein substrates 
to neighboring cells.  The T4SS was originally found in Agrobacterium tumefaciens, 




possessing bacteria have a wide and varied range of target cells in luding animal, plant, 
fungal, and bacterial cells [194]. 
Two basic T4SS have been characterized: the Agrobacterium VirB/D4 and the 
Legionella Dot/Icm (a.k.a. Icm/Dot) secretion systems.  Given the loose definition of the 
T4SS, a distinction between the differing ultra-structural T4SS types was necessary as 
subsequent organisms were found to possess varying T4SS [199].  Designated as A and 
B, relative to the Agrobacterium VirB/D4 and Legionella Dot/Icm systems respectively 
[200]. 
The VirB/D4 T4SS is encoded by two operons, virB and virD having 11 and 5 
genes respectively [195].  The virB operon codes for the cell envelope spanning and 
extracellular filament extrusion structure of the type four A secretion system (T4ASS) 
structural apparatus, whereas the virD genes code proteins associated with T-DNA 
transfer via the T4ASS [195]. 
The L. pneumophila Dot/Icm type IV B secretion system (T4BSS) includes a 
series of 26 genes coded on two separate pathogenicity islands in the genome called 
region I (RI) and region II (RII) [199], each of which consist of d t and/or icm genes.  
Fourteen of these genes show homology to the conjugal transfer apparatus of the tra/trb 
genes of the R64 and col1b-P9 self-transmissible IncI class onjugation plasmids [199, 
201].  Though the homology of the T4BSS genes demonstrate relatedness to these 
plasmid transfer systems, evidence indicates that the T4BSS machine has been modified 
to transport effector proteins to the host cell [199]. 
Investigations into the intracellular growth requirements of L. pneumophila 




multiplication (icm) genes required for intracellular growth in macrophages [202, 203].  
Most of the T4BSS dot/icm genes (25/26) exist within either region I or II with the only 
exception being DotV which resides exterior to these regions [199]. 
The physical structure of the L. pneumophila T4BSS is currently being 
characterized.  Using a variety of genetic and biochemical analyses, a L. pneumophila 
T4BSS core transmembrane spanning structure demonstrated functional onservation 
with the distantly related Agrobacterium VirB7-10 T4ASS subcomplex [204].  In L. 
pneumophila the core structure is composed of a dimer pair of DotF and DotG prteins 
that extends from the inner to the outer membrane where they independently associate 
with DotH/DotC/DotD proteins [204].  This well designed core transmembrane model of 
the L. pneumophila T4BSS may prove similar for the C. burnetii T4BSS. 
The location of the remaining proteins of the L. pneumophila T4BSS was 
determined using a combination of differential centrifugation and western blot analysis to 
identify protein associations with the outer membrane, periplasm, cytoplasm and/or inner 
membrane of the bacterium.  The outer membrane associated protein DotK has a transient 
association with DotC and DotD prior to these (DotC and DotD) associating with the core 
transmembrane structure (DotF, DotG, and DotH) on the inner face of the outer 
membrane [204].  The periplasm contains IcmX and DotH, with DotH then moving on to 
its association with the core structure on the outer membrane face [204].   The IcmQ, 
IcmR, DotB, IcmS, and IcmW proteins were all located in the cytoplasm [204].  The 
inner membrane shows the greatest number of T4BSS associated protins and includes 




IcmV with DotF and DotG interacting initially with the inner mebrane prior to their 
association with the core complex of the T4BSS [204]. 
Various studies on the function of individual L. pneumophila T4BSS proteins have 
been performed identifying protein specific activities of the L. pneumophila T4BSS.  
Substrate adapters were identified in DotU and IcmF that act to stabilize DotH as L. 
pneumophila transitions to its virulent stationary phase [205].  Additionally, a homo-
hexameric ring of DotB proteins was identified that ac s as a functional ATPase, likely 
providing the energy necessary to drive the T4BSS machinery [206].  It was also noted that 
DotB has significant homology to the PilT family ofproteins known to mediate pilus 
retraction, which may be indicative of an additional function for the DotB protein [206, 
207].  IcmS and IcmW appear to form a complex to mediat  substrate/protein interactions 
for translocation via the T4BSS into the host cell [208, 209].  A bacterial two-hybrid screen 
using DotF as bait found that it interacts with a variety of secreted substrates [210].  IcmR 
was found to bind to the N-terminal region of IcmQ in a chaperone/substrate relationship 
and to act as a regulatory protein for IcmQ function [211, 212].  IcmQ was also shown to 
insert into lipid membranes and form pores which allow the dye calcein, but not Dextran 
3000, to efflux the lipid membrane.  This suggests a pore size restriction for effector 
substrates via the IcmQ pore [212].  The DotF data supports a model where DotF form an 
integral component of the transmembrane structure for the core T4BSS, and requires DotF 
to be capable of interacting with all T4BSS substrates.  The IcmQ data also fit this model in 
that IcmQ may serve as an inner membrane pore allowing certain substrates to enter into the 




The C. burnetii genome sequence revealed both type I and II secretion systems and 
two loci within a 33kb span of DNA containing ORFs that have a high degree of homology 
to the T4BSS genes of L. pneumophila [137, 199].  Of the 26 L. pneumophila T4BSS genes, 
homologs of 23 appear to be encoded in the C. burnetii genome [213].  Of these 23 genes of 
the C. burnetii T4BSS, 22 are encoded within the two gene/linkage groups (designated 
Region I and II, respectively) of the 33kb span.  The sequence homology and genetic 
organization of the C. burnetii and L. pneumophila T4BSS genes led to the assumption that 
C. burnetii has a functional T4BSS which is used to secrete effector proteins into its host 
cell. 
To determine whether the putative C. burnetii T4BSS proteins are functionally 
homologs, complementation studies expressing cloned C. burnetii genes in L. pneumophila 
T4BSS mutants were performed.  Combined, these studie  indicate that the C. burnetii 
T4BSS genes icmS, icmW, dotB, and icmT (in one model) could complement the 
corresponding L. pneumophila mutants, while icmQ, icmP, icmO, icmJ, icmB, and icmX 
could not [214, 215].  Another study analyzed total RNA from Vero cells infected with 
avirulent C. burnetii NMII using RT-PCR and found icmS, icmW, icmQ, and dotB were 
expressed by 48 hours PI, with cmW detected as early as 24 hours PI [214].  While the C. 
burnetii T4BSS is strikingly similar to the L. pneumophila T4BSS, differences do exist that 
preclude complementation with all homologous proteins.  Considering the differing life-
cycles and environments in which they replicate, this is not surprising. 
Figure 1.1 shows a physical map of the genetic loci for the L. pneumophila and C. 
burnetii T4BSS.  Region’s I and II show a high similarity in composition and orientation of 




























































































genes that separate the convergent dotA and dotB genes, while in the C. burnetii region I a 
single non-T4BSS gene exists between icmW and icmX.  Region II of L. pneumophila shows 
one gene (lpg0457) which separates the convergent T4BSS genes icmF and dotO, while the 
C. burnetii region II has no non-T4BSS genes and ends with do O; the C. burnetii dotU and 
icmF lie outside of the region.  The L. pneumophila T4BSS icmR, dotJ/icmM and dotV 
genes apparently do not have equivalent genetic homologs in the C. burnetii T4BSS [213].  
The genome sequence information showing T4BSS homologs in C. burnetii extends 
previous work that had identified randomly sequenced C. burnetii fragments with homology 
to the L. pneumophila T4BSS proteins [216]. 
Though not extensively characterized, the regulation of RNA expression within L. 
pneumophila Regions I and II was analyzed by constructing nine Icm::lacZ fusions [217].  
Site-directed and PCR random mutagenesis of these fusions identified DNA regulatory 
elements.  The icmT, icmP, icmQ, icmM, icmV, icmW, and icmR genes were all found to 
contain a 6-bp sequence (TATACT) essential for their expression.  Primer extension showed 
this sequence serves as their -10 promoter element.  In addition, sequences upstream of 
icmV, icmW, and icmR contained regulatory elements appearing to serve as binding sites for 
transcriptional regulators.  Altogether, twelve regulatory elements, seven of which constitute 
the -10 promoter of the icm genes, were found upstream of eight icm genes [217].  Unlike L. 
pneumophila, which has between 91 and 400 bp of non-coding sequence upstream of genes 
that start transcriptional units within the T4BSS [217], the C. burnetii T4BSS has a more 
compact gene arrangement.  Only icmW, icmV, icmT, dotD, icmQ, and dotP have more than 
90 bp of non-coding sequence upstream, and none had more than 262 bp.  Many of the 




addition, the C. burnetii sequences upstream of  icmW, icmV, icmT, dotD, icmQ, and dotP 
has no apparent bacterial (E. coli) consensus -10 sequences (TATAAT) or other readily 
recognizable regulatory elements (E. I. Shaw, unpublished observations). 
Analysis of the C. burnetii RI locus shows the divergence of three gene groupings 
(Figure 1.1): icmX←CBU1651←icmW, icmV→dotA, and CBU1646←dotB←dotC←dotD 
←icmS←icmT.  As a result of the genetic orientation of these loci, the transcriptional 
regulatory mechanisms and products of these gene linkage groups (not precluding each 
individual ORF’s regulation) are likely to be coordinately regulated.  Characterization of the 
regulation of C. burnetii’s T4BSS RI will provide significant insight into the expression of 
this virulence mechanism during infection. 
In L. pneumophila, the T4BSS is essential for secreting proteins involved in bacterial 
intracellular trafficking and replication within macrophages.  As discussed, the C. burnetii 
NMI genome sequence revealed ORFs with significant homology and organized into two 
regions similar to those found in the L. pneumophila T4BSS.  Currently, little else is known 












Since its discovery in 1935 in both the United States and Australia, C. burnetii has 
come to be recognized as a naturally obligate intracellular pathogen that causes acute (Q 
fever) and chronic infections in humans [12].  Animal reservoirs of C. burnetii 
(particularly ruminants) can develop chronic infections and shed environmentally stable 
infectious particles that can be acquired by humans and other animals via inhalation [218, 
219].  After inhalation, C. burnetii infects alveolar macrophages, where it replicates 
within a PV [122]. Once inside a host cell, C. burnetii exhibits a bi-phasic life cycle that 
starts with the environmentally stable SCV form and then changes i to the metabolically 
active and replicative LCV form [120, 121].  While both forms are infctious in tissue 
culture models [128], SCVs are thought to be the primary form associ ted with naturally 
acquired infections [122]. 
Like many pathogenic intracellular bacteria, C. burnetii induces phagocytosis 
[168] and uses host cell materials (e.g., amino acids, nucleotides, etc.) to its advantage 
[167, 168, 220-222].  Upon infection, C. burnetii is trafficked along the endocytic 
pathway and eventually resides within vacuoles that retain many features of mature 
phagolysosomes [169, 179, 181, 223-226].  However, it has been shown that C. burnetii 
trafficking along the endocytic pathway is delayed for approximately two hours post 
infection (hpi) [177] and that as early as five minutes PI the C. burnetii PV appears to 
associate with the LC3 marker of the autophagy pathway [179, 180, 225].  After an initial 
24 to 48 hour lag in replication, the organism replicates every 10 to 12 hours until 
approximately six days PI when asynchronous conversion back to SCVs begin  within 




The enlargement and maintenance of the C. burnetii containing PV is dependent 
on C. burnetii proteins [187, 188].  Studies employing bacteriostatic concentrations of 
chloramphenicol, carbenicillin, and nalidixic acid to inhibit bacterial protein synthesis, 
cell wall synthesis, and DNA replication, respectively, demonstrated that C. burnetii 
specific effectors are involved in host-pathogen interactions [187, 188].  Infected cells 
treated with chloramphenicol early during infection contain small, tightly bound LAMP-1 
positive PVs containing a single C. burnetii organism that dispersed throughout the host 
cell [187].  However, with removal of the chloramphenicol, vacuolar fusion re ccurred 
and resulted in spacious PVs containing multiple C. burnetii [188].  C. burnetii infected 
cells treated with carbenicillin or nalidixic acid were found to have mature spacious PVs 
containing multiple non-replicating C. burnetii, suggesting that vacuolar development 
requires metabolically active C. burnetii and is not dependant on bacterial density for 
complete PV maturation [187, 188].  Recent reports show a series of C. burnetii encoded 
Ankyrin repeat domain containing proteins that are secreted into the host cell cytoplasm 
[227, 228].  These proteins have been shown to associate with the PV membran , 
microtubules, and mitochondria when expressed ectopically in eukaryotic cells [227].   In 
addition, C. burnetii actively mediates inhibition of host cell apoptosis by activating Akt 
and Erk1/2 [229], which presumably prolongs its opportunity for intracellular replication 
[229, 230]. 
Secretion systems specifically involved in virulence include the typ III and type 
IV secretion systems (T4SS).  Secretion systems have been found in a wide array of 
extracellular, facultatively intracellular, and obligate intracellular pathogens [191, 192, 




bacterial conjugation systems modified to export virulence factors.  These factors include 
nucleoprotein complexes and effector proteins that secrete directly into a host or into the 
extracellular milieu [194, 196, 199].  At present, the type IV category has been 
subdivided into two families, (i) the VirB/D4 T4ASS and (ii ) the Dot/Icm T4BSS [194]. 
The categorical T4ASS is found in Agrobacterium tumefaciens [194, 231, 232].  
It has been shown to be used for direct injection of effector molecules into adjacent cells  
[194] or into the extracellular environment [233, 234].  These attributes of the T4ASS are 
a major virulence mechanism and a key factor in the molecular pathogenesis of bacteria 
possessing these systems [199, 232, 235].  T4ASS are composed of up to twelve gen s 
encoding a pilus-like structure that transverses the inner membrane, periplasmic space, 
and outer membrane of Gram-negative bacteria [231].  Localization analyses of the A. 
tumefaciens T4ASS indicated that it is expressed polarly on the cell surface [236-239]. 
The L. pneumophila genome encodes an Lvh system, which has significant 
homology to the T4ASS system of A. tumefaciens [199].  Although shown to be present 
and expressed, the T4ASS of L. pneumophila has little affect on its virulence [240].  
Alternately, L. pneumophila encodes a T4BSS that has been shown to be essential for its 
survival and pathogenesis within the host cell.  The Dot/Icm system of L. pneumophila 
best characterizes the second subdivision of the type IV secretion system family, T4BSS 
[194].  This system is composed of 26 dot/icm genes that form the T4BSS complex 
encoded in two distinct pathogenicity islands designated RI and RII.  As with the A. 
tumefaciens T4ASS, localization studies of the L. pneumophila T4BSS indicate polar 





Analysis of the C. burnetii RSA 493 (Nine Mile phase I strain) sequence revealed 
loci with significant homology and gene organization to both RI and RII of the L. 
pneumophila T4BSS [137].  This information extended previous work that had identified 
randomly sequenced C. burnetii fragments with similarity to L. pneumophila T4BSS 
genes [216]. The genome sequence, combined with studies using C. burnetii T4BSS 
analogs (IcmW, DotB, IcmS, and IcmT) to complement the respective L. pneumophila 
mutants [214, 215], led to the assumption that C. burnetii utilizes a T4BSS that is 
functionally akin to the L. pneumophila system.  Studies have shown the L. pneumophila 
T4BSS is required for intracellular survival, effector protein secretion, and replication 
within host cells [202, 203, 244-248], indicating its vital role for L. pneumophila 
pathogenesis.  The descriptive functionality of the T4BSS system in C. burnetii is 
lacking. 
Expression studies of the C. burnetii T4BSS gene homologs have been limited 
both in the number of gene homologs analyzed as well as the breadth of the temporal 
analysis.  One study analyzed total RNA collected 24, 48, and 96 hpi from cultured cells 
infected with C. burnetii Nine Mile phase II using reverse transcriptase PCR (RT-PCR) and 
found that gene specific transcripts for icmS, icmQ, and dotB were detectable by 48 hpi 
while icmW transcript was detectable as early as 24 hpi [214].  Other data showed that icmS 
and dotC transcripts were present by 8 hpi, with dotB transcripts present by 24 hpi, and 
icmW transcript present as early as 6 hpi [249, 250].  An additional study using 
quantitative reverse transcriptase PCR (RT-qPCR) demonstrated that a dotA transcript is 




The C. burnetii T4BSS RI loci contains twelve genes (CBU1652 – CBU1641), 
nine of which are obvious homologs of L. pneumophila T4BSS genes [137].  Figure 1.1 
shows a physical map of the twelve C. burnetii genes: (i) icmX←CBU1651←icmW, (ii ) 
icmV→dotA→CBU1647, and (iii ) CBU1646←dotB←dotC←dotD←icmS←icmT. 
Considering the infectious life cycle of C. burneti, the genetic arrangement of the 
T4BSS loci in C. burnetii, and the importance of the T4BSS as a virulence factor in other 
bacterial pathogens, I sought to address the following questions: 
1. Is the transcription and translation of the C. burnetii T4BSS RI genes 
temporally regulated throughout the course of the infectious cycle?  







In nature, Coxiella burnetii is an obligate intracellular bacterium and the causative 
agent of acute Q fever.  This pathogen invades eukaryotic host cells wh re it is able to 
reside and replicate within a PV that has attributes of a phagolysosome.  Analysis of the 
C. burnetii NMI genome revealed ORF’s with significant homology to the L. 
pneumophila T4BSS, a known virulence mechanism.  In C. burnetii, little is known about 
the expression and sub-cellular localization of T4BSS proteins and the role they play in 
establishing and/or maintaining an infection.  Here, temporal expression analysis of both 
mRNA and protein expression/ultra-structure for the C. burnetii T4BSS Region I gene 
homologs was analyzed during infection of host cells.  First, I demonstrated the efficacy 
of a novel technique to isolate enriched bacterial specific RNA from infected cells.  This 
method resulted in up to 1,300 fold increase in C. burnetii specific RNA compared to 
traditional TRI Reagent lysis methods.  Subsequently, the C. burnetii RI T4BSS genes 
were shown to be expressed in three transcriptionally linked groups which quantitative 
PCR then demonstrated to be expressed at the highest levels early during infection. This 
correlates to temporally expression changes in these genes as C. burnetii is trafficked 
early during infection and shifts from SCV→LCV forms of the bacteria.  Next, I found 
that C. burnetii IcmT increased significantly (p < 0.05) from 0 to 24 hours post infecton 
(hpi), and was then maintained from 24 to 168 hpi.  Additionally, I demonstrate th  the 
C. burnetii T4BSS is expressed polarly on the C. burnetii LCV form by 8 hpi and 
remains polar through 168 hpi.  These data led me to conclude that the C. burnetii T4BSS 
RI is temporally regulated at both the RNA and protein level and that the T4BSS is 






A METHOD OF ISOLATING ENRICHED BACTERIAL RNA FROM CELLS 





The obligate intracellular bacterium Coxiella burnetii is the causative agent of Q 
fever, a human illness that is normally acquired through an aerosol route and manifests 
with flu-like symptoms [12]. C. burnetii invades a host cell, is trafficked along the 
endocytic pathway, establishes residence, and replicates intracellul rly within a 
membranous bound parasitophorous vacuoles (PV) with characteristics of a 
phagolysosome [178]. The obligate nature of C. burnetii during infection makes 
acquiring enriched or purified C. burnetii RNA which is representative of in vivo RNA 
expression a challenge due to (i) the time required to isolate intracellular bacteria from 
host cells prior to RNA isolation, and (ii ) the short half-life of bacterial RNA.  For these 
reasons C. burnetii RNA expression studies have primarily been performed using total 
RNA from C. burnetii infected host cells where the vast majority of the harvested RNA is 
eukaryotic [214].  This limits the downstream techniques which can be employed for C. 
burnetii specific gene expression studies, most notably Northern blot and RNA
microarray analysis.  While the growth of C. burnetii in a cell-free environment was 
recently demonstrated [251], this significant achievement does not eliminate the need to 
develop means of analyzing the gene expression of these bacteria in their intracellular 
environment. 
Commonly used C. burnetii purification methods have included osmotic lysis 
[252], cell homogenizing/disruption [253, 254], and sonic disruption of cells [173], which 
can result in the generation of bacterial aerosols.  Considering the risks involved with C. 
burnetii’s manipulation and the difficulty purifying C. burnetii away from host cell 
material, new methods to safely and efficiently purify this pathogen are significant.  The 




while absent from the C. burnetii membrane, led to the recent development of a digitonin 
based C. burnetii purification method [255]. This method is advantageous as it occurs in 
a closed system, providing a safe alternative to traditional C. burnetii harvesting 
techniques [255].  This method has proven successful for the isolation of infectious C. 
burnetii [255] and recently has been employed in our laboratory to isolate infectious 
Rickettsiae (unpublished data). However, the possibility of modifying this method to 
produce stable RNA samples which are enriched for C. burnetii RNA has not been 
explored. 
I co-developed a new protocol for isolation of RNA from intracellular C. burnetti 
cells in human cell lines.  The method involves key modifications of the sucrose 
phosphate digitonin (SPD) lysis method [255], specifically, the addition of GeneLock™ 
(Sierra Molecular Inc., Sonora, CA), a DNA/RNA stabilizing solutin [256], to protect 
the C. burnetii RNA during the bacterial enrichment process and performing the entire 
protocol on ice. I compare the level of bacterial RNA enrichment in parallel RNA 
samples that were isolated from infected cells using this approach (which I describe as 
SPD-GL/ice) to:  1) bacteria enriched by SPD lysis at room te perature (SPD/rt) as 
previously isolated [255],  2) bacteria enriched by SPD lysis on ice (SPD/ice),  3) SPD 
lysis with 20% GeneLock™ in the lysis solution at room temperature (SPD-GL/rt), to 
demonstrate the level of enrichment of the bacterial fraction as well as the stability of the 
RNA obtained using this SPD-GL/ice approach. 
Confluent Vero cells (CCL-81, American Type Culture Collection) were infected 
with C. burnetii Nine Mile, Phase II, clone 4 RSA439 (CBII), at a genome equivalent 




supplemented with 5% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) in an 
atmosphere of 5% CO2 at 37°C with regular media changes.  Infected cells were 
maintained until an infection rate of ~70% was observed by phase contrast light 
microscopy at ~3 weeks post infection.  The C. burnetii-infected Vero (CBII/Vero) cells 
were then trypsinized (Mediatech, Inc., Herndon, VA) and split into T-75 cm2 cell culture 
flasks for all downstream experiments described below. The CBII/Vero cells were then 
allowed to propagate to confluency (approximately 2 days) reaching an infection rate of 
>90% as observed by indirect immunofluorescence antibody (IFA) assay.  A 
representative IFA is hown in Figure 3.1. 
Enrichments were performed by removing the culture medium from infected 
monolayers, followed by washing cells once with SP buffer (250 mM sucrose, 12.8 mM 
KH2PO4, 72.6 mM NaCl, 53.9 mM Na2HPO4 at pH 7.4) to remove residual medium.  
SPD-GL buffer (SP buffer containing digitonin at 0.2 mg ml-1 and GeneLock™ solution 
added to 20% of the final volume) was then added (10ml per T-75 cm2 culture flask).  
Flasks were incubated on ice for 30 min. with moderate rocking during which time cell 
lysis occurs [255].  Cell lysates were then collected into 15 ml conical tubes and 
centrifuged at 1,200  g for 15 min at 4 °C to pellet host cellular debris.  Supernatants 
were then transferred to new 15ml tubes and centrifuged for 10min. at 13,000  g at 4°C 
to pellet the released C. burnetii.  The supernatant fluid was discarded and the C. burnetii 
pellets were solubilized in 1ml of TRI Reagent® Solution (Ambion, Austin, TX), 





Figure 3.1: IFA assay of 
3-week post infection single field IFA micrograph images.  Panel A, DAPI (Sigma, St. 
Louis, MO) stained cell nuclei (blue).  Panel B, 
antibody against whole-
Alexa Fluor® 488 conjugated antibody (Molecular Probes, Eugene, OR).  Panel C, 
merged A/B image (Paint.NET v3.35), showing >90% 
Vero cells.  Micrograph images were captured via a Nikon DS FI1 camer  on a Nikon 




IFA as ay of Coxiella burnetii NMII infected Vero cells. Panel series A
C. burnetii cells (green), primary rabbit 
killed C. burnetii NMII with secondary goat anti








For comparative purposes, this procedure was repeated using parallel CBII/Vero 
cells along with SPD lysis buffer with GeneLock™ at room temp rature (SPD-GL/rt), 
with SPD lysis buffer with no GeneLock™ (SPD/rt), and with SPD lysis buffer with no 
GeneLock™ on ice (SPD/ice). 
Total RNA from each of the crude C. burnetii pellets produced using the SPD and 
SPD-GL enrichment methods was isolated following standard TRI Reagent® Solution 
protocols (Ambion).  All total RNA preparations were then DNased for one hour with 
RQ1 DNase (Promega, Madison, WI), followed by phenol extraction and nucleic acid 
precipitation.  The resulting precipitates were resuspended in nuclease free H2O.  To 
further remove small DNA and RNA species, single nucleotides, and potential protein 
residue, each sample was lithium chloride precipitated following the Ambion Lithium 
Chloride Precipitation solution protocol (Ambion Technical sheet 9480). Each RNA 
sample was then confirmed as DNA free via PCR analysis usingGoTaq PCR Master Mix 
(Promega, Madison, WI) and primers CB652 (forward) 5'– 
ACGGGTGAGTAATGCGTAGG and CB653 (reverse) 5'– 
GGGCTTTCACATCCGACTTA [257] designed against the C. burnetii 16S rrs 
ribosomal gene. To demonstrate integrity of the RNA, RNA samples (300ng/sample) 
from each isolation method was analyzed using an Agilent 2100 Bioanalyzer On-chip gel 
electrophoresis analysis system (Agilent Technologies, Inc., Waldbronn, Germany) and 
the microfluidic RNA 6000 Nano Labchip® kit (Agilent Technologies, Inc.). 
The level of enrichment of bacterial RNA in all above procedures was compared 
to total, un-enriched RNA harvested directly from CBII/Vero monolayers using TRI 




samples).  In order to quantify the relative enrichment of C. burnetii vs. Vero cell RNA 
from each isolation method, I used reverse transcriptase quantitative PCR (RT-qPCR) 
analysis and the 2-∆∆CT relative fold comparison method to compare Vero 18S and C. 
burnetii rrs (16S) rRNA cycle threshold (CT) values.  qPCR primer sets for (a) eukaryotic 
18S and (b) rrs were: (a) Hs18S-F (forward) 5’ – CATTCGAACGTCTGCCCTAT, 
Hs18S-R (reverse) 5’ – CAATTACAGGGCCTCGAAAG  [257], (b) Q16s-F (forward) 
5’ – CCATGAAGTTGGAATCGCTAG (forward), Q16s-R (reverse) 5’ – 
ACTCCCATGGTGTGACGG [129].  Both primer sets were tested to etermine primer 
efficiency and found to be within the efficiency window for the 2-∆∆CT relative fold 
calculation method [258].  Single step RT-qPCR analysis utilizing SuperScript™ III 
(Invitrogen, Carlsbad, CA) reverse transcriptase and the SYBR Green Master Mix Kit 
(Applied Biosystems, Foster City, CA) was performed on an ABI 7500 cycler using 10ng 
of total RNA per reaction.  To calculate the fold enrichment values for sample sets the 
18S gene CT values were used as the primary reference standard (1° ∆CT), with the C. 
burnetii rrs gene CT values functioning as the internal secondary reference (2° ∆CT) for 
each sample set respectively.  Fold enrichment values were then compared to each other 
to determine the relative ratio of fold differences between each RNA isolation method.  
Statistical significance between the methods was evaluated usingthe single factor 
ANOVA method with a 95% confidence interval by MS Excel 2007 (Microsoft, 
Redmond, WA).  To determine statistical significance, a minimum of two biological 
replicates having no less than four technical replicates each were used. 
Figure 3.2 shows a representative densitometry plot image of the corresponding 
chromatographic data for each sample.  Bands representative of eukaryotic 18S and 28S 
 
 
Figure 3.2: Agilent 2100 Bioanalyzer On
CBII/Vero RNA.  Lane 1
SPD/rt enriched RNA, Lane 4
RNA, Lane 6- SPD-GL/ice enriched RNA. 
3 – 6 indicate a significant 





-chip gel electrophoresis densitometry plot of 
- Agilent RNA Ladder, Lane 2- TR isolated total RNA, Lane 3
- SPD/ice enriched RNA, Lane 5- SPDGL/rt enriched 
 Lanes 2 – 6 show RNA integrity, while lanes 







rRNA can be seen in Figure 3.2, lanes 2-6, with little to no non-specific/degraded RNA, 
demonstrating the integrity of the RNA samples produced by all methods.  The 
appearance of prokaryotic 16S and 23S rRNA bands in Figure 3.2, lanes 3 – 6, suggest  
that C. burnetii RNA is substantially enriched by the SPD and SPD-GL methods relative 
to the TR sample (lane 2).  This qualitative evidence indicates an enrichment of C. 
burnetii RNA species occurs within a given total RNA sample following the crude 
enrichment of C. burnetii by the SPD and SPD-GL methods when compared to a 
standard RNA isolation technique. 
A quantitative measure of the relative enrichment of C. burnetii RNA following 
bacterial enrichment compared to total RNA harvested directly from infected cells is 
depicted in Figure 3.3.  When comparing equal amounts of total RNA, the quantitative 
data indicate that the SPD-GL/ice method enriches C. burnetii rrs RNA to a 1,377:1 ratio 
relative to TR isolation, while the SPD-GL/rt to TR ratio is 366:1.  In analyzing the 
enrichment without GeneLock™, it was found that the SPD/ice to TR C. burnetii RNA 
ratio was 350:1, while the SPD/rt to TR ratio was 26:1.  These data indicate that 
significant increases exist in the relative amount of C. burnetii RNA to Vero cell RNA 
after digitonin lysis and differential centrifugation.  Comparing the enrichment method 
with or without GeneLock™ in the solution indicate its usefulness in tabilizing RNA.  
Figure 3.3 shows that the SPD-GL/ice to SPD/ice ratio is ~4:1, while the SPD-GL/rt to 
SPD/rt ratio is 14:1.  Comparing the effects of performing the enrichments on ice vs. rt, 
indicates that there is a 3.7:1 ratio when comparing SPD-GL/ice relative to SPD-GL/rt, 
and a 13.5:1 ratio when comparing SPD/ice to SPD/rt.  These calculations indicate that (i) 





Figure 3.3: Fold enrichment of C. burnetii rrs RNA harvested by various methods.  RT-
qPCR using 10ng of RNA samples isolated by TR, SPD, or SPD-GL methods at room 
temperature (rt) or on ice.  Relative C. burnetii rrs fold values are as follows: TR acts as 
the relative standard and yields a fold value of 1, SPD/rt yields a 26 (error +9), SPD/ice a 
350 (error + 28), SPD-GL/rt a 366 (error + 56) and SPD-GL/ice a 1,377 (error + 186) 





GeneLock™ during the enrichment is roughly equivalent to performing it on ice alone, 
and (iii ) performing the enrichment on ice using GeneLock™ provided the greatest 
relative C. burnetii RNA enrichment.  Using single factor ANOVA at 95% confidence 
interval, significant differences were confirmed between all comparative methods 
analyzed except when comparing the SPD-GL/rt relative to the SPD/ice methods 
(approximate 1:1 comparative fold value ratio).  Overall, these data indicate that the 
utilization of SPD-GL/ice yields an increase of C. burnetii rrs RNA relative to either 
SPD-GL/rt or SPD/ice at an approximate 4:1:1 ratio. 
The ability to isolate total RNA from infected cell culture that is enriched for the 
bacterial fraction may expand the downstream techniques available for xpression 
analysis.  Commercial bacterial RNA enriching products such as Microbe Enrich 
(Ambion) has been reported for isolating the RNA of obligate intra-cytoplasmic 
Rickettsiae spp. [256, 259].  However, these products may be cost prohibitive, 
particularly when analyzing multiple growth conditions and time points or when 
obtaining large scale amounts of RNA.  Using SPD-GL/ice to enrich for obligate 
intracellular bacteria prior to RNA isolation allows experiments to be scaled-up for the 
acquisition of enriched RNA from very large numbers of infected cells. In addition, other 
than the digitonin and GeneLock™, the buffers are composed of chemicals common to 
molecular biology laboratories. 
In summary, I have demonstrated the development of a simple, safe, inexpensive 
method to significantly enrich the RNA of C. burnetii harvested from infected host cells 
by modifying a recently described digitonin lysis method [255] with the addition of the 




performing the entire process on ice further enhances the enrichment.  While there is 
undoubtedly some C. burnetii RNA lost during the procedure, the quality of the SPD-
GL/ice enriched RNA may prove useful for in vivo RNA expression analysis techniques 
where total RNA with relatively lower amounts of host cell RNA would be advantageous.  
The method described here may well be applicable to the isolation of e riched bacterial 






EXPRESSION ANALYSIS OF COXIELLA BURNETII (NMII) 
TYPE IVB SECRETION SYSTEM REGION I GENES 




Coxiella burnetii is an obligate intracellular pathogen that causes acute (Q f ver) 
and chronic infections in humans [12].  Animal reservoirs of C. burnetii (particularly 
ruminants) can develop chronic infections and shed environmentally stable infectious 
particles that can be acquired by humans and other animals via inhal tion [218, 219].  
After inhalation, C. burnetii infects alveolar macrophages, where it replicates within a 
parasitophorous vacuole (PV) [122]. Once inside a host cell, C. burnetii exhibits a bi-
phasic life cycle which starts with the environmentally stable small cell variant (SCV) 
form, then changes into the metabolically active and replicative larg  cell variant (LCV) 
form [120, 121].  While both forms are infectious in tissue culture models [128], SCVs 
are thought to be the primary form associated with naturally acquired infectio s [122]. 
Like many pathogenic intracellular bacteria, C. burnetii induces phagocytosis 
[168] and uses host cell materials (e.g., amino acids, nucleotides, etc.) to its advantage 
[167, 168, 220-222].  Upon infection, C. burnetii is trafficked along the endocytic 
pathway and eventually resides within vacuoles that retain many features of mature 
phagolysosomes [169, 179, 181, 223-226].  However, it has been shown that C. burnetii 
trafficking along the endocytic pathway is delayed for approximately two hours post 
infection (hpi) [177] and that as early as five minutes post infection the C. burnetii PV 
appears to associate with the LC3 marker of the autophagy pathway [179, 180, 225].  
After an initial 24-48 hour lag in replication, the organism replicates every ten to twelve 
hours until approximately six days post infection when asynchronous conversion back to 
SCVs begins within the PV [129], and continues until host cell lysis. 
The enlargement and maintenance of the C. burnetii containing PV is dependent 




chloramphenicol, carbenicillin, and nalidixic acid to inhibit bacterial protein synthesis, 
cell wall synthesis, and DNA replication, respectively, demonstrated that C. burnetii 
specific effectors are involved with host-pathogen interactions [187, 188]. Infected cells 
treated with chloramphenicol early during infection contained small tightly bound 
LAMP-1 positive PVs containing single C. burnetii  that were dispersed throughout the 
host cell [187].  However, with the removal of the chloramphenicol, vacuolr fusion 
reoccurred and resulted in spacious PVs containing multiple C. burnetii [188].  C. 
burnetii infected cells treated with carbenicillin or nalidixic acid were found to have 
mature spacious PVs containing multiple non-replicating C. burnetii, suggesting that 
vacuolar development requires metabolically active C. burnetii and is not dependant on 
bacterial density for complete PV maturation [187, 188].  Recent reports show a series of 
C. burnetii encoded Ankyrin repeat domain containing proteins are secreted into the h st 
cell cytoplasm [227, 228].  These proteins have been shown to associate with the PV 
membrane, microtubules, and mitochondria when expressed ectopically within eukaryotic 
cells [227].   In addition, C. burnetii actively mediates inhibition of host cell apoptosis by 
activating Akt and Erk1/2 [229], which presumably prolongs its opportunity for 
intracellular replication [229, 230]. 
Secretion systems specifically involved in virulence include the typ III and type 
IV secretion systems (T4SS).  These systems have been found in a wide array of 
extracellular, facultatively intracellular, and obligate intracellular pathogens [191, 192, 
196-198].  The T4SSs has been subdivided into two groups, the type IVA secretion 
system (T4ASS), encoded by the virB operon [199], and the type IVB secretion systems 




pneumophila, where it is also known as the dot/icm system [202, 216, 248, 260, 261].  
While the T4ASS and the T4BSS share some homologies, T4ASS have 12 or fewer 
ORFs while the T4BSS have 23 – 26 ORFs [137, 199].  L. pneumophila’s T4BSS has 
been shown to be essential for effector protein secretion, bacterial intr cellular 
trafficking, and replication within macrophages as well as amoeba [202, 203, 244-247].  
Analysis of the C. burnetii RSA 493 (Nine Mile phase I strain) genome sequence 
revealed loci with significant homology and gene organization to both Region I and 
Region II of the L. pneumophila T4BSS [137].  This information extended previous work 
which had identified randomly sequenced C. burnetii fragments with similarity to L. 
pneumophila T4BSS genes [216]. The genome sequence, combined with studies using C. 
burnetii T4BSS analogs (IcmW, DotB, IcmS, and IcmT) to complement the respective L. 
pneumophila mutants [214, 215], led to the assumption that C. burnetii utilizes a T4BSS 
that is functionally akin to the L. pneumophila system.  Gene expression studies of the C. 
burnetii T4BSS homologs have been limited both in the number of homologs analyzed as 
well as the breadth of the temporal analysis.  One study analzed total RNA collected 24, 
48, and 96 hpi from cultured cells infected with C. burnetii Nine Mile phase II (NMII) using 
reverse transcriptase PCR (RT-PCR) and found that gene specific transcripts for icmS, 
icmQ, and dotB were detectable by 48 hpi while cmW transcript was detectable as early as 
24 hpi [214].  Other data showed that icmS and dotC transcripts were present by 8 hpi, 
with dotB transcripts present by 24 hpi, and icmW transcript present as early as 6 hpi 
[249, 250].  An additional study using quantitative reverse t anscriptase PCR (RT-qPCR) 
demonstrated that dotA transcript is detectable by 8 hpi with a peak in expr ssion per 




To more fully characterize the transcriptional and translational regulation of the 
C. burnetii T4BSS, I analyzed the RNA expression profile of the Region I (RI) genes at 
numerous points over a time course of infection.  The C. burnetii T4BSS RI loci contain 
twelve genes (CBU1652 – CBU1641), nine of which are L. pneumophila T4BSS 
homologs [137].  As shown in Figure 4.1 (a), the orientations of the twelve C. burnetii 
genes are suggestive of three operons: (i) icmX←CBU1651←icmW, (ii ) 
icmV→dotA→CBU1647, and (iii ) CBU1646←dotB←dotC←dotD←icmS←icmT.  To 
assess the temporal regulation of C. burnetii T4BSS RI homologs during the course of 
the infectious cycle, synchronous C. burnetii infection of host cells using purified SCVs 
[129] was employed, followed by RT-PCR and RT-qPCR using RNA samples purified 
from infected host cells at early, mid, and late stages of infection.  I identified 
transcriptional linkages between the C. burnetii T4BSS RI homologs and defined their 
relative expression levels during an infectious cycle.  Additionally, the correlation 
between protein and RNA expression of IcmT was assessed to determin  relative protein 





Figure 4.1: Coxiella burnetii Type IVB Secretion System Region I gene map.  Panel a.  
Physical map of C. burnetii T4BSS RI.  Solid arrows represent T4BSS homologs.  Open 
arrows represent non-T4BSS ORFs.  Gene designations are indicated above each ORF.  
Panel b. Agarose gel image(s) showing RT-PCR products corresponding to co-
transcribed genes from Linkage Group i, ii , and iii  (correlating to the diamond tipped 
lines in Panel a).  L, 100 bp DNA ladder (size designated on left).  +RT, with reverse 




MATERIALS AND METHODS 
Bacterial Cultivation and Purification.  C. burnetii Nine Mile Phase II Clone 4 
(NMII) was propagated in African green monkey kidney (Vero) cells in RPMI medium 
with 5% fetal bovine serum (FBS) and the SCV form of the organism was isolated as 
previously described [129].   The SCV isolation was performed using digitonin lysis of 
host cells followed by low speed and high speed differential centrifugat on to isolate C. 
burnetii cells similar to published methods [255].  Briefly, C. burnetii infected Vero cells 
were rinsed once with sucrose phosphate (SP) buffer,  followed by lysis of the eukaryotic 
cells in SP buffer (pH 7.4), 0.2mg/ml digitonin.  The lysate was then removed and 
subjected to a 4,000  g centrifugation to pellet host cell debris.  The supernatant 
containing C. burnetii SCVs was then subjected to 12,000  g centrifugation to pellet the 
SCVs.  The crude SCV pellet was then resuspended in SPG buffer (0.7M sucrose, 3.7mM 
KH2PO4, 6.0mM K2HPO4, 0.15M KCl, 5.0mM glutamic acid, pH 7.4) and stored at -
80°C.  Organisms were enumerated by genome equivalents using qPCR [138]. 
Cell culture and infection.  Vero cells were propagated in RPMI 1640 media 
containing 5% FBS with gentamicin (20 µg/ml) at 37°C and 5% CO2.  Culture media 
without antibiotics was added two hours prior to bacterial infection that was carried out in 
the same media.  Vero cells were infected with C. burnetii NMII at an MOI of 0.5, 
resulting in 40% infection.  After two hours (designated as time 0), the inoculum was 
removed, the cells were washed once with PBS and infected cultures incubated in RPMI, 
5% FBS at 37°C, and 5% CO2 for periods of 0, 8, 16, 24, 36, 48, 96, and 168 hpi.  To 




parallel infections were either treated with the RNA synthesis inhibitor rifampin (+Rif) at 
20µg/ml in the culture media or mock treated (-Rif) and harvested for total RNA. 
RNA isolation and quality control.  Total RNA was harvested from infected tissue 
cultures at various times post-infection using TRI Reagent® (Ambion, San Antonio, TX).  
In some cases, enriched C. burnetii RNA was isolated using a modification of the 
digitonin based bacterial isolation method [255].  The addition of GeneLock™ (Sierra 
Molecular, Sonora, CA) to 20% in the lysis solution was found to protect th  in egrity of 
the RNA during bacterial enrichment while substantially enriching the relative amount of 
C. burnetii specific RNA in a given sample (J. K. Morgan and E. I. Shaw, submitted).  
All RNA samples were DNase treated to remove contaminating DNA with RQ1 DNase 
(Promega, Madison, WI). 
RNA analysis.  RT-PCR analysis was carried out using the Access Quick RT-PCR 
Kit (Promega) following the manufacturer’s instructions.  Alloligonucleotide primers 
used in this study (Integrated DNA Technologies, Coralville, IA) are shown in Table 4.1.  
Forward [f] and reverse [r] primer pairs: CB58 [f] and CB57 [r] ( icmW – CBU1651 – 
icmX), CB59 [f] and CB60 [r] (icmV – dotA), CB603 [f] and CB602 [r] (dotB – 
CBU1646), CB63 [f] and CB64 [r] (dotD – dotC – dotB), and CB62 [f] and CB61 [r] 
(icmT – icmS – dotD) were used to demonstrate transcriptional linkage.  Full-length RT-
PCR analysis of icmT, icmV, and icmW was performed using CB78 [f] and CB79 [r], 
CB70 [f] and CB71 [r], and CB40 [f] and CB41 [r], respectively. 
Oligonucleotide  primers (Table 4.1) for RT-qPCR analysis of icmX, icmW, icmV, 
dotA, dotB, and icmT were designed using Primer3Plus [257]. The C. burnetii rrs (16S) 




TABLE 4.1: Oligonucleotide primers used in this study. 
Gene Target RefSeq ID Designation Gene Primer Sequence (5’→ 3’) Purpose 
rrs1 CBU 16S Q16s-Ff  CCATGAAGTTGGAATCGCTAG RT-qPCR 
  Q16s-Rr  ACTCCCATGGTGTGACGG RT-qPCR 
     
icmT CBU 1641 CB62f  GCAAAATCGCCATAGCATGGTG RT-PCR 
  CB578f  GGGATGGCAAAACAGCCTTT RT-qPCR 
  CB579r  CCGTCACCGCTACGATGAG RT-qPCR 
  CB78 f 2CACCATGAAATCTCTCGATGAGG PCR, RT-PCR 
  CB79 r 3TTAGTTATCCCACCATGCTATGG PCR, RT-PCR 
     
dotD CBU 1643 CB63f  TCCAGACGGATCATTGAGC RT-PCR 
  CB61r  CAACGCCAGAAAGAGGGGCAGC RT-PCR 
     
dotB CBU 1645 CB64r  CAATGTGTTTGGGTTCGAAGCG RT-PCR 
  CB603f  ACTCGACAGTGATCCCGAAC RT-PCR 
  CB586f  CCACGGGTTCGGGTAAAAG RT-qPCR 
  CB587r  GCGCTTCGGCCAATTCT RT-qPCR 
     
glycine betaine 
transporter4 
CBU 1646 CB602r  TTACCCAGCGGCGTTAATAC RT-PCR 
     
dotA CBU 1648 CB60r  CGATAATGCCTTCATTGAGC RT-PCR 
  CB654f  ACAATCAATCCCCGTTGAAA RT-qPCR 
  CB655r  AGCTATCATCGCCTGGCTTA RT-qPCR 
     
icmV CBU 1649 CB59f  TTCCAAATGAAGCAACGC RT-PCR 
  CB592f  TGGCGGGTTACACGGTTT RT-qPCR 
  CB593r  CGCAGACGAAAGCCGATAA RT-qPCR 
  CB70 f 2CACCATGATTCTTTTGGAGTCTTC
C 
RT-PCR 
  CB71r 3TTATTGTTTGGACCCCTTAAAGGT
G 
RT-PCR 
     
 icmW CBU 1650 CB58f  CAAACTCTTGAGGAAGG RT-PCR 
  CB594f  CGCCGCTGCGAAAGTG RT-qPCR 
  CB595r  ACCGGCGGTGTCTATTTCC RT-qPCR 
  CB40f 2CACCATGCCAGATCTGTCGC RT-PCR 
  CB41r 3TTATAAACCACCTTCCTCAAGAG RT-PCR 
     
icmX  CBU 1652 CB57r  GAAGCAATACCAAGAACACG PCR, RT-PCR 
  CB658f  CCGCTTATAATTCGGACCAA RT-qPCR 
  CB659r  TTGATAAGCGGGATTGTTCA RT-qPCR 
1rrs, primers designed by Coleman, S.A., et al., 2004 [129]. 
 2CACC, non-C. burnetii sequence, engineered directional cloning sequence for pET200/D-TOPO plasmid. 
 3TTA, non-C. burnetii sequence, engineered stop codon. 
 4glycine betaine transporter, Beare, P.A., et al., 2009 (supplemental data table) [262]. 




empirically tested to determine primer efficiency and found to be within the efficiency 
window for the 2-∆∆CT relative fold calculation method [258, 263].  Single step RT-qPCR 
analysis using SuperScript III (Invitrogen, Carlsbad, CA) reverse transcriptase and the 
SYBR Green Master Mix Kit (Applied Biosystems, Foster City, CA) was performed on 
an ABI 7500 cycler.  Each reaction contained a total of 15µL and included 20ng of total 
RNA.  To determine the calculated fold values for sample sets, the C. burnetii rrs CT 
values were used as the primary reference standard (1° ∆CT), with respect to each gene of 
interest as the internal secondary reference (2° ∆CT) for each RNA sample set, 
respectively.  Statistical significance between the time points was evaluated by single 
factor ANOVA with a 95% confidence interval using MS Excel 2007 (Microsoft, 
Redmond, WA).  A minimum of three biological replicates having no less than four 
technical replicates were used for each time point. 
Recombinant IcmT purification and antibody production.  The C. burnetii icmT 
ORF was PCR amplified using CB78 [f] and CB79 [r], and Vent polymerase (New 
England Biolabs, Ipswich, MA).  The resulting PCR product was ligated into the 
pET200/D-TOPO (Invitrogen) vector, clonally isolated using E. coli TOP10 cells, and its 
sequence verified (clone designation, GA39).  The recombinant plasmid (pGA39) was 
transformed into the E. coli BL21 strain DE3 (Invitrogen) and protein expression was 
induced using IPTG.  His-tagged IcmT was purified using nickel chelation 
chromatography according to the manufacturer’s instructions (Thermo Fisher Scientific, 
Rockford, IL).  Recombinant IcmT was used as antigen to produce IcmT specific 




University’s Institutional Animal Care and Use Committee protocls.  Serum was stored 
at -80°C until use.  
C. burnetii IcmT expression analysis.  C. burnetii NMII infected Vero cells 
growing on 12 mm glass coverslips in 24 well plates were fixed at 0, 8, 16, 24, 48, 96, 
and 168 hpi with 4% paraformaldehyde and 0.05% Tween-20 in PBS for 15 minutes at 
room temperature.  Indirect immunofluorescent antibody (IFA) analysis was performed 
using a guinea pig polyclonal antibody against whole C. burnetii NMII and rabbit 
polyclonal antibody against C. burnetii recombinant IcmT.  The secondary antibodies 
were goat anti-guinea pig IgG Alexa Fluor® 555 (red) and goat anti-rabbit IgG Alexa 
Fluor® 488 (green) (Molecular Probes, Eugene, OR).  Micrograph images wer  captured 
via a Nikon DS FI1 camera on a Nikon Eclipse TE 2000-S microscope at 400 
magnification, with NIS-Elements F 3.00 software.  Micrograph capture settings were 
uniform for all images (Tiff file format).  Using a modification of a method previously 
used in C. burnetii studies which employs relative pixel ratios in sample quantitation 
[264], each micrograph image was analyzed using ImageJ version 1.42n (Wayne 
Rasband, NIH) software.  Five fields of view from each of three biological samples were 
digitally captured for each time sampled.  The matching 555 and 488 images were 
stacked (paired) and converted to grey scale (8bit, see Figure 4.4 inset).  No fewer than 
five regions of interest (ROI) were then selected from the 555 wavelength grey scale 
images in a blind fashion.  The pixel density within the ROIs from each stacked image 
were then measured as previously published [265].  The mean pixel densities were then 
compared to obtain the 555:488 ratio for each micrograph ROI.  These individual ratios 




of IcmT compared to whole C. burnetii NMII.  The final 555:488 (C. burnetii:IcmT) ratio 
for each time point was then divided into the 0 hpi ratio to obtain the final IcmT relative 
expression levels.  Statistical significance between each time point was evaluated using 




Transcriptional linkage within the C. burnetii T4BSS Region I.  The C. burnetii 
T4BSS RI gene linkage map is suggestive of three contiguous ORF groups made up of 
transcriptionally linked genes (see Figure 4.1).  These include: (i) 
icmX←CBU1651←icmW, (ii ) icmV→dotA→CBU1647, and (iii ) 
CBU1646←dotB←dotC←dotD←icmS←icmT.  To demonstrate transcriptional linkage 
between the genes, I performed RT-PCR analysis using oligonucletide primers (see 
Table 4.1) designed to span intergenic sequences and/or adjoining ORFs.  The diamond-
ended lines in Figure 4.1 (a) indicate the position of primers and DNA products that 
would result from RT-PCR amplification.  Using total RNA harvested from Vero cells 
infected with C. burnetii NMII (three weeks pi) as template, amplification products were 
observed (Figure 4.1 b) for each linkage region: (i) icmW – icmX, (ii ) icmV – dotA, and 
(iii ) icmT – dotD, dotD – dotB, dotB – CBU1646 (Figure 4.1 b).  Taken together, these 
data indicate that the C. burnetii T4BSS RI is expressed as three operons without 
precluding the potential for additional transcriptional regulation within the operons. 
De novo synthesis of C. burnetii T4BSS genes.  It has been previously reported in 
Chlamydia trachomatis and C. burnetii that significant amounts of RNA exist within 




utility of the mRNA carried from one host cell infection to the next is unknown.  To 
determine when de novo synthesis of mRNA for C. burnetii T4BSS genes begin post 
infection, I used RT-PCR analysis on total RNA samples collected from C. burnetii NMII 
infected Vero cells, which had been enriched for the C. burnetii RNA fraction (J. K. 
Morgan and E. I. Shaw, submitted).  Vero cells were inoculated for tw  hours with C. 
burnetii NMII (0 hpi represents the end of the two hour inoculation) and enriched total 
RNA samples were collected at 8 hpi from rifampin treated (+Rif) and mock-treated (-
Rif) samples.  Using RNA from mock-treated samples as template, RT-PCR produces 
amplicons representing the presence of full-length mRNA by 8 hpi for icmT, icmV, and 
icmW; the first genes within each of the T4BSS RI linkage groups (Figure 4.2).  In 
contrast, the rifampin-treated samples show no detectable RT-PCR amplification 
products for these genes (Figure 4.2).  Together, these data indicate that by 8 hpi T4BSS 
RI transcripts carried into the cell by SCVs had degraded and that e novo transcription 
was occurring for the three genes assayed. 
Relative transcript levels of icmX, icmW, icmV, dotA, dotB, and icmT during 
infection.  To determine the temporal expression of mRNA from the three C. burnetii 
T4BSS RI linkage groups over a time course of infection, I used RT-qPCR to quantify 
the relative amounts of the first and last genes from each RI linkage group.  Figure 4.3 
shows a graphical representation of the relative abundance for icmX, icmW, icmV, dotA, 
dotB, and icmT transcripts as a function of time.  These data points represent the relative 
fold ratio as calculated by the 2-∆∆CT method [258, 263] in which I normalized each gene 
transcript to the C. burnetii rrs (16S rRNA), and then to the 96 hpi time point (lowest 





Figure 4.2:  RT-PCR detection of full-length C. burnetii T4BSS transcripts, icmT, icmV, 
and icmW.  RNA template was isolated at 8 hpi from rifampicin-treated (+Rif) and mock-
treated (-Rif) cells.  L, 100 bp DNA ladder (size designated on left).  +RT/-Rif, with 
reverse transcriptase and mock-treated.  -RT/-Rif, without revers  transcriptase and 
mock-treated.  +RT/+Rif, with reverse transcriptase and rifampin-treated.  -RT/+Rif, 







Figure 4.3:  Relative transcript fold changes for C. burnetii icmX, icmW, icmV, dotA, 
dotB, and icmT over a time course of infection.  Left and right columns are the first and 
last gene from each Linkage Group, respectively.  Top, middle, and bottom rows correlate 
to Linkages Groups i, ii , and iii  respectively.  Time of total RNA harvest in hpi is 
indicated below the X-axis.  The results represent the mean of three biological samples 
with no fewer than three technical replicates of each sample.  Standard error bars 





attributable to carryover mRNA present within SCVs upon infection, and are not thought 
to represent functional transcript in the current infection.  
Analysis of the 8 – 36 hpi transcript levels indicates that active regulation is 
ongoing for each of the genes during the early stages of the infectious ycle.  This time 
frame (8 to 36 hpi) corresponds to the late lag phase of a C. burnetii infection of a host 
cell [129].  Analysis of Linkage Group i genes indicates that there is a statistically 
significant decrease in the relative expression of icmW between 8 and 16 hpi (p < 0.05) 
and 24 to 36 hpi (p < 0.05), and 8 to 24 hpi (p < 0.05) for icmX.  A statistically significant 
increase (p < 0.05) then occurs in the relative amount of icmX mRNA from 24 to 36 hpi.  
Linkage Group ii  shows a significant (p < 0.05) decrease in relative expression from 16 to 
36 hpi for icmV, and from 8 to 16 and 24 to 36 hpi for dotA; however, at 16 and 24 hpi 
the relative levels of dotA mRNA are not statistically different (p > 0.05) during 
infection.  In Linkage Group iii , icmT transcript levels decrease from 8 to 36 hpi (p < 
0.05); whereas, dotB shows a significant increase (p < 0.05) in relative mRNA levels 
from 8 to 16 hpi followed by a significant decrease (p < 0.05) from 16 to 36 hpi.  
Interestingly, transcript levels for each gene analyzed shows a significant increase (p < 
0.05) between 36 and 48 hpi, then a synchronous decrease in relative transcript levels 
between 48and 96 hpi, followed by another increase at 168 hpi.  These times (96 and 168 
hpi) represent the exponential and early stationary phase of the C. burnetii infectious 
cycle, respectively [129].   
IcmT expression during infection.  To determine the relative expression of a C. 
burnetii T4BSS protein, I analyzed IcmT expression over the course of an infectious 




hpi.  Using guinea pig antibodies against whole cell C. burnetii NMII and rabbit 
antibodies against recombinant C. burnetii IcmT, I performed dual staining IFA 
microscopy assays.  Figure 4.4, Panels A and B show representative color (RGB) 
micrograph images illustrating the Alexa Fluor® 555 and 488 secondary antibody binding 
to the guinea pig (red, Figure 4.4, Panel A) and rabbit antibodies (green, Figure 4.4, Panel 
B), respectively.  Inset panels A and B show 8-bit grayscale micrograph conversions of 
the RGB images (Figure 4.4, Panels A and B).  The pixel data in the grayscale images 
was used in the analysis of Region(s) of Interest (ROI).  The ROI from paired images 
were equal in area and selected in an arbitrary fashion after conversion of the images 
from RGB to grayscale.  The pixel density of the paired ROIs wa used to measure the 
relative amount of whole C. burnetii to IcmT by calculating the 555:488 fluorescence 
intensity ratios [264, 265].  Cross fluorescent illumination (bleed-through) of both the 
Alexa 555 and 488 did not occur under these conditions (data not shown).  Figure 4.5 is a 
representation of this data relative to 0 hpi.  My analysis reveal d that from 0 to 24 hpi, 
there is a significant increase (p < 0.05) in the amount of IcmT relative to whole C. 
burnetii at each time point between 0 to 24 hpi.  From 24 to 168 hpi, there is not a 
statistically significant (p > 0.05) change detected and relativ y uniform levels of IcmT 
are maintained throughout the duration of the infectious cycle (Figure 4.5).  These data 





Figure 4.4:  Representative dual channel IFA micrograph images (RGB and grayscale) of 
C. burnetii infected Vero cells.  Panels a (Alexa® 555/red) and b (Alexa® 488/green), 
show dual channel micrographs (400X magnification) of the same field of view taken 96 
hpi using 555 and 488 wavelength filters.  The Alexa® 555 labeled (red) antibody is 
binding anti-C. burnetii guinea pig IgG, and the Alexa® 488 labeled (green) antibody is 
binding anti-IcmT rabbit derived IgG, respectively.  Inset images are 8 bit (gray scale) 





Figure 4.5:  Relative IcmT expression over a time course of infection.  Pixel density 
ratios of whole C. burnteii:IcmT (555:488) from digital images captured at 0, 8, 16, 24, 
48, 96, and 168 hpi were converted to quotient values relative to 0 hpi.  Error ba s 





During a C. burnetii infection of a host cell, questions of when the bacteria begin 
to actively manipulate host cell processes, what bacterial mechanisms are involved, and 
to what extent this is sustained throughout the infection remain of considerable interest.  
The homology and similarity of organization between the C. burnetii and L. pneumophila 
T4BSS genes [137] suggested that C. burnetii possesses a functional T4BSS.  To that end, 
L. pneumophila has been utilized as a surrogate model for testing C. burnetii T4BSS 
homolog functionality [213].  Complementation studies using C. burnetii icmS, icmW, 
dotB, and icmT homologs in L. pneumophila T4BSS mutants demonstrated that these 
proteins were functional analogs to the L. pneumophila proteins.  However, C. burnetii 
icmQ, dotM, dotL, dotN, dotO, and icmX homologs could not complement the respective 
L. pneumophila mutant [214, 215].  Interestingly, these studies show that four of five C. 
burnetii T4BSS RI genetic homologs were able to complement the L. pneumophila 
T4BSS mutants whereas none of the five RII genetic homologs could cmplement, 
suggesting a functional distinction exists between the L. pneumophila and C. burnetii 
T4BSSs.  Nevertheless, these studies provide strong evidence that the C. burnetii T4BSS 
is involved in host cell parasitism. 
Here I sought to determine whether the expression of the C. burnetii T4BSS RI 
genes are temporally regulated during infection by characterizing the transcript levels for 
icmX, icmW, icmV, dotA, dotB, and icmT along with the relative protein levels of IcmT.  
My analysis indicates that the C. burnetii RI Linkage Groups (Figure 4.1 a) are expressed 






(ii ) icmV→dotA 
(iii ) CBU1646←dotB←dotC←dotD←icmS←icmT 
However, this method does not preclude the possibility for internal genespecific 
promoters which might further regulate the RI ORFs.   
It is well documented that bacterial genes whose products function as a unit are 
often grouped into operons, and it appears that C. burnetii has evolved a similar 
mechanism for the T4BSS.  Sequence data from the C. burnetii genome indicate that the 
T4BSS ORFs within each linkage group have little non-coding intervening sequences 
[137].  Only icmW, icmV, icmT, dotD, icmQ, and dotP have more than 90bp of non-coding 
sequence upstream and none had more than 262 bp.  The compact nature of the C. burnetii 
T4BSS contrasts with that of the L. pneumophila system in that the L. pneumophila 
T4BSS has non-coding sequences upstream of transcriptional units which range f om 91 
to 400 bp [217].  Many of the linked C. burnetii T4BSS RI genes have very few bases 
separating them which may allow efficient transcription of the C. burnetii T4BSS genes. 
Here I show that the initial gene from each of the C. burnetii T4BSS RI linkage 
groups (icmT, icmV, icmW) (Figure 4.1) are synthesized de novo as full-length transcripts 
by 8 hpi (Figure 4.2) using a comparison of rifampin-treated and mock-treated samples.  
The use of a bacterial RNA synthesis inhibitor to demonstrate de novo RNA synthesis 
provides confirmation that previous studies where C. burnetii T4BSS icmS and dotC 
transcripts were detected by 8 hpi, dotB transcripts by 24 hpi, as well as icmW transcripts 
as early as 6 hpi [249, 250] were likely detecting de novo synthesized mRNA.  De novo 




RT-qPCR [129].  Predictably, comparisons of +Rif and mock treated samples harvested 
later during infection demonstrated that de novo synthesis of RNA continued when RT-
PCR assays were performed (data not shown).  Therefore, it is unlikely that carry-over 
RNA within an SCV makes a substantial contribution in the translation of proteins during 
the early stages of infection of a host cell.  I used samples harvested at 8, 16, 24, 36, and 
48 hpi to analyze the expression of C. burnetii T4BSS as it relates to early events of 
infection such as bacterial trafficking and SCV-to-LCV conversion.  While these data 
show the presence of C. burnetii T4BSS transcripts by 8 hpi, it is likely that T4BSS 
expression may begin even earlier during the infectious process.  Electron microscopy 
evidence showing SCV to LCV conversion by 8 hpi [129] also suggests that bacterial 
transcription within the host cell may begin earlier during the infection process. 
RT-qPCR analysis was used to define the relative expression of the first and last 
gene of each Linkage Group: (i) icmW and icmX, (ii ) icmV and dotA, and (iii ) icmT and 
dotB, over a time course of infection.  I used RNA samples harvested at 8, 16, 24, 36, 48, 
96, and 168 hpi after synchronous infections were initiated by inoculation with SCVs.  
Within the C. burnetii infectious cycle, these samples correspond to (i) early vesicle 
trafficking and the conversion of SCVs to LCVs (8 to 36 hpi), (ii  pronounced metabolic 
activity and C. burnetii LCV replication (48 to 96 hpi), and (iii ) the beginning of an 
asynchronous reversion back to the SCV form (168 hpi) [120, 121, 129].  These data 
showed significant temporal RNA regulation for each of the genes a alyzed throughout 
the time course of infection.  In each case, the lowest RNA levels in relation to overall 
transcription were seen at 96 hpi.  All of the genes showed the highest relative expression 




abundance of transcripts for each of the T4BSS genes analyzed was found to have 
decreased significantly by 36 hpi (Figure 4.3).  Interestingly, each of the C. burnetii 
T4BSS homologs analyzed by RT-qPCR revealed a significant increase in relative 
transcripts at 48 hpi (Figure 4.3).  The 36 to 48 hpi period represents the end of the SCV 
to LCV lag phase, and the initial burst of replication and a heightened metabolic activity 
for the bacteria [129].  The trends from 48 to 168 hpi are relatively uniform for all of the 
genes analyzed with the lowest relative amounts at 96 hpi.  However, it is noteworthy 
that a slight, although significant, increase is detected from 96 to 168 hpi.  This 
corresponds to the asynchronous conversion of C. burnetii LCVs to SCVs [129] and may 
be associated with the mix of LCVs and SCVs present in the PV at that time. 
Defining the relative expression of a C. burnetii T4BSS protein in relation to its 
RNA expression during an infection was carried out by measuring the relative quantity of 
C. burnetii IcmT.  Using fluorescent microscopy, I observed IcmT 0 hpi indicating it is 
likely present in infectious SCVs.  I observed a significant increase in C. burnetii IcmT 
expression between each time point analyzed during the first 24 hpi (0 to 8 hpi, 8 to 16 
hpi, and 16 to 24 hpi, respectively).  From 24 to 168 hpi, my observations indicated th  
the relative IcmT quantity did not change to a statistically significant degree (p > 0.05) 
(Figure 4.5).  It is unclear whether the IcmT detected at 0 hpi has functional utility, 
although two possibilities for the IcmT detected at 0 hpi are: (i) it is part of a functional 
T4BSS structure poised to act upon uptake by a host cell, or (ii ) it is not part of a 
functional T4BSS structure but is available for quick assembly once taken up by a host 
cell.  Combined with my RT-qPCR analysis, these data suggest that C. burnetii T4BSS 




to 24 hpi) and becomes relatively uniform for the duration of the infecton (24 to 168 
hpi).  A close comparison of Figure 4.3 (icmT) and Figure 4.5 reveals that IcmT 
expression is higher following a rise in icmT transcript levels and decreases following a 
decrease in transcripts (Figure 4.3 and Figure 4.5, 24 to 48 hpi).  High RNA expression 
early during infection corresponds to a rapid rise in IcmT protein levels from a low at 0 
hpi.  Predictably, this suggests that transcription leads directly to a subsequent increase or 
decrease in translation for IcmT.  The relationship between the RNA and corresponding 
IcmT protein expression indicates that temporal regulation of icmT transcription and 
IcmT protein expression exists during the C. burnetii infectious cycle. 
In summary, I have shown that the C. burnetii T4BSS RI is expressed as a set of 
three operons and that de novo transcription and translation of C. burnetii T4BSS genes is 
present as early as 8 hpi.  How much earlier expression of these genes may begin is 
unknown at this time.  In addition, I have shown that the first 24 hpi is vital with respect 
to an increase of both transcription and translation for these genes.  Transcript and protei  
levels for C. burnetii T4BSS RI genes at later stages of an infection (48 to 168 hpi) 
appear to be relatively constant.  These data provide a substantial increase in our 
understanding of the temporal regulation of the C. burnetii T4BSS and when this 






POLAR LOCALIZATION OF THE COXIELLA BURNETII DOT/ICM 




The zoonotic disease Q fever is caused by C. burnetii, an obligate intracellular 
bacterial pathogen [12] which has only recently been propagated in a cell-free media 
[251].  During a normal intracellular infectious cycle within its host cell, C. burnetii lives 
in a parasitophorous vacuole (PV) with many of the attributes of a mature phagolysosome 
[169, 179, 181, 223-226].  Recent studies have shown that C. burnetii protein synthesis is 
required for the pathogen to affect host cell processes, such as apoptosis  [229] and 
vesicle trafficking  [187, 188], at sites distant to the PV.  Sequence analysis of the C. 
burnetii strain (RSA493) Nine Mile phase I genome revealed a set of genes with 
homology to the Dot/Icm type IV secretion system (T4BSS) found in Legionella 
pneumophila [137].  In addition, the genome sequence revealed C. burnetii ORFs 
containing eukaryotic Ankyrin binding repeat domains [227, 228].  Subsequently, these
ORFs have been shown to be secreted by L. pneumophila in a T4BSS dependant manner 
[227, 228], further implicating the C. burnetii T4BSS as a significant factor in cellular 
pathogenesis.  In L. pneumophila, the T4BSS system consists of twenty-six ORFs of 
which twenty-three share significant homology with C. burnetii ORFs [137].  Studies 
have clearly shown that the L. pneumophila T4BSS is required for intracellular survival, 
effector protein secretion, and replication within host cells [202, 203, 244-248].  Thus, 
the T4BSS plays a vital role in the infectious process of L. pneumophila, however 
characterization of the T4BSS system in C. burnetii during an infection is lacking. 
Polar localization of bacterial virulence factors has been recognized in both 
Gram-negative and Gram-positive bacterial pathogens.  Type IV secretion systems export 
virulence factors which includes nucleoprotein complexes and effector proteins that are 




secretion systems have been subdivided into two families, (i) the VirB/D4 (T4ASS) and 
(ii ) the Dot/Icm (T4BSS) systems [194]. The T4ASS of Agrobacterium tumefaciens has 
been shown to directly inject effector molecules into adjacent cells  [194] as well as into 
the extracellular environment [233, 234].  VirB8, part of the core complex, was reported 
to localize at the pole of A. tumefaciens cells approximately 50 – 65% of the time [238] 
and the bacterium has been shown to attach to plant host cells at the b c erial poles [268].  
The T4BSS system in L. pneumophila is essential for cellular pathogenesis and has been 
shown to secrete numerous effector proteins into a host cell [199, 231].  In addition, L. 
pneumophila type IVB secreted substrates LidA, SidC, and SdeC, and one T4BSS 
component, DotF, has been shown to have a polar localization [210, 241-243]. 
Further virulence factors that have been shown to localize or disperse about the 
pole(s) of Gram-negative and Gram-positive bacteria include alternte secretion systems, 
effector protein molecules, and surface membrane associated proteins.  For instance, 
evidence suggests that the type III secretion system of Shigella flexneri is present on the 
poles of the bacteria prior to the secretion of the IpaC protein [269].  Recently, the 
Mycobacterium marinum Esx-1 type VII secretion system was shown to secrete substrate, 
Mh3864, at the poles and that a core Esx-1 component, Mh3870, localized preferentially 
to the poles [270].  Type V autotransporter secretion shows polar localizing proteins that 
are crucial to Gram-negative bacterial virulence and include AIDA-I  (Escherichia coli), 
BrkA (Bordetella pertussis), IcsA and SepA (Shigella flexneri) [271].  The NalP 
autotransporter from the Gram-negative cocci Neisseria meningitides has also been 
shown to localize to the poles of transformed E. coli cells expressing the protein [271].  




the bacterial pole where it is involved in invasion and actin-based motility [272]. These 
examples underscore a wide array of mechanisms in which bacterial virulence stratagems 
have polar localization. 
C. burnetii’s ability to effect host cell function while sequestered in the PV, and 
the observation that many secretion systems and virulence mechanisms localize pol rly in 
numerous pathogenic bacteria led me to investigate the sub-cellular localization of the C. 
burnetii T4BSS.  Using antibodies specific to the C. burnetii IcmT, IcmV, and DotH 
homologs, I demonstrate by IFA that IcmT, IcmV, and DotH localize to one or both poles 
of the bacterium and confirm these findings using immunoelectron microscopy.  This is 
the first demonstration of the localization of this virulence machinery during a C. burnetii 
infection of host cells. 
 
MATERIALS AND METHODS 
Bacterial Cultivation and Purification.  C. burnetii Nine Mile Phase II Clone 4 
(NMII) was propagated in African green monkey kidney (Vero) cells in RPMI medium 
with 5% fetal bovine serum (FBS) and the SCV form of the organism was isolated as 
previously described [129].   The SCV pellet was then resuspended in SPG buffer (0.7M 
sucrose, 3.7mM KH2PO4, 6.0mM K2HPO4, 0.15M KCl, 5.0mM glutamic acid, pH 7.4) 
and stored at -80°C.  Organisms were enumerated by genome equivalents using qPCR 
[138]. 
Cell culture and infection.  Vero cells were propagated in RPMI 1640 media 
containing 5% FBS with gentamicin (20 µg/ml) at 37°C and 5% CO2.  Culture media 
without antibiotics was added two hours prior to bacterial infection that was carried out in 




resulting in 40% infection.  Infected cells cultures were incubated in RPMI, 5% FBS at 
37°C, and 5% CO2 for 3 weeks. 
Expression plasmid construction.  Oligonucleotide primers used for the PCR 
amplification of icmT, icmV, and dotH from C. burnetii NMII genomic DNA were, icmT: 
5’ – CACCATGAAATCTCTCGATGAGG (Forward) and 5’ – 
TTAGTTATCCCACCATGCTATGG (Reverse), icmV: 5’ – 
CACCATGATTCTTTTGGAGTCTTCC (Forward) and 5’ – 
TTATTGTTTGGACCCCTTAAAGGTG (Reverse), dotH: 5’ – 
CACCATGGTGATTCGAAAAATTTTCC (Forward) and 5’ – 
TTACAACCCTTCAATCATCAAC (Reverse).  Underlined and italicized bases, CACC 
and TTA, are non-C. burnetii sequences used for directional cloning and stop codon 
creation, respectively.  Blunt PCR products from each gene were ligated into the 
pET200/D-TOPO vector and transformed into E. coli TOP10 cells according to the 
manufacturer’s instructions (Invitrogen, Carlsbad, CA).  Selected lones were cultivated 
at 37˚C in Luria-Bertani (LB) broth containing 50 µg/ml Kanamycin and sequence 
verified. The clones were designated GA39 (icmT), GA44 (icmV), and GA36 (dotH). 
Recombinant protein purification.  Plasmids pGA39, pGA44, and pGA36 were 
electroporated into E. coli BL21 (DE3) cells (Invitrogen, Carlsbad, CA) and protein 
production was induced following the manufacturer’s instructions (Invitrogen).  The cells 
were then pelleted by centrifugation at 6,000  g for 20 minutes and isrupted in lysis 
buffer (50mM Tris, 200mM NaCl) using sonication.  Inclusion bodies were p ll ted at 
27,000  g for 15 min and then solubilized using a modification of a previously 




sarcosinate (sarkosyl) at 10% (v/v).  The repelleted inclusion bodies were then 
solubilized using 0.3% sarkosyl in Tris buffer (50mM Tris, 300mM NaCl) nd allowed to 
incubate at room temperature with agitation.  Insoluble particulates were cleared by 
centrifugation at 20,400  g for 15 minutes.  The solubilized His-tagged proteins were 
purified using nickel chelation chromatography according to the manufacturer’s 
instructions (Thermo Fisher Scientific, Rockford, IL).  SDS-PAGE gels and MALDI-
TOF or Orbitrap mass spectrometry analysis at the Oklahoma State University 
Recombinant DNA/Protein Core Facility was used to confirm the content of each 
recombinant protein preparation.  The quantity of purified recombinant proteins was 
determined using a BCA™ protein assay kit according to the manufacture’s 
specifications (Pierce).  Purified recombinant proteins were stored at -80˚C. 
Antibody production and purification.  The production of polyclonal antibodies 
against recombinant IcmT, IcmV, and DotH protein was performed in accordance to the 
Oklahoma State University Institutional Animal Care and Use Committee protocol.  
Briefly, New Zealand White rabbits were injected with 1mg/ml of recombinant protein in 
Freund's complete adjuvant (Sigma-Aldrich) for the primary injection and Freund's 
incomplete adjuvant for subsequent injections.  IFA and immune-blotting were us d to 
confirm antibody reactivity and protein specificity.  Exsanguination was preformed via 
cardiac puncture and serum separated from whole blood by centrifugation at 8,200  g 
for 15 minutes.  IgG fractions were then enriched using Protein-A cross-linked agarose 
beads according to the manufacturer’s instructions (Pierce).  Each antibody was then 




polyclonal antibodies were then absorbed against E. coli BL21 (DE3) cells fixed in a 4% 
(w/v) paraformaldehyde, 0.05% (v/v) Tween-20 in PBS solution. 
Indirect Immunofluorescent Antibody analysis.  Vero cells infected with C. 
burnetii NMII (three weeks post infection) were seeded to 12mm glass coverslips in 24 
well plates and allowed to adhere overnight.  Adherent cells were th n fixed using a 4% 
(w/v) paraformaldehyde, 0.05% (v/v) Tween-20 in PBS solution for 15 minutes at room 
temperature.  Indirect immunofluorescent antibody (IFA) analysis was performed using a 
guinea pig polyclonal antibody against whole C. burnetii NMII and rabbit polyclonal 
antibody against C. burnetii recombinant IcmT, IcmV, and DotH.  The secondary 
antibodies were goat anti-guinea pig IgG Alexa Fluor® 555 (red) and goat anti-rabbit IgG 
Alexa Fluor® 488 (green) (Molecular Probes, Eugene, OR).  To stain bacterial and host 
Vero cell nucleic acids, 4', 6-diamidino-2-phenylindole (DAPI) was included with the 
secondary incubation.  Micrograph images were captured via a Nikon DS FI1 camera on 
a Nikon Eclipse TE 2000-S microscope at 600  magnification, with NIS-Elements F 
3.00 software.  All micrograph size and merge (RG or RGB) functions were performed 
universally for the associated micrographs using ImageJ version 1.42n (Way e Rasband, 
NIH) software. 
Immunoelectron microscopy.  To observe the localization of DotH, IcmT, and 
IcmV at the ultra-structural level, heavily infected Vero cells (see above) were prepared 
for progressively low temperature embedding IEM.  Infected cells were trypsinized, 
pelleted, and fixed on ice for 1 hour in PBS containing 4% paraformaldehyde (v/v), 
0.05% glutaraldehyde (v/v).  The Washington University, Department of Molecular 




performed the sample processing and immune electron microscopy anal sis. Samples 
were embedded in 2% agarose and rinsed extensively in dH20 prior to en bloc staining 
with 1% aqueous uranyl acetate (Ted Pella Inc., Redding, CA) for 1 h ur.  Samples were 
subsequently dehydrated in a graded series of ethanol at progressively lower 
temperatures, infiltrated with LR Gold resin (Ted Pella Inc.) at -20°C, and polymerized 
under UV light.  Samples were sectioned with a Leica Ultracut UCT ultramicrotome 
(Leica Microsystems Inc., Bannockburn, IL).  Sections were blocked with 5% fetal 
bovine serum/5% goat serum for 30 minutes and subsequently incubated overnight at 4°C 
with primary antibodies against IcmT, DotH, and IcmV, respectively.  Sections were then 
washed in blocking buffer and probed with anti-rabbit IgG (H+L) conjugated to 18 nm 
colloidal gold (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 1 hour 
at room temperature.  Sections were washed in phosphate buffer followed by an extensiv  
water rinse and stained with uranyl acetate and led citrate.  Samples were viewed with a 
JEOL 1200EX transmission electron microscope (JEOL USA Inc., Peabody, MA).  
Additional samples were also processed for cryo immunoelectron microscopy as 
previously described [274].  Cryo IEM sample fixation and section probing were 
performed as described above for IcmT, DotH, and IcmV.  The labeling experiments for 
both progressively low temperature embedding and cryoimmunoelectron microscopy 
were conducted in parallel with controls omitting the primary antibody.  These controls 
were consistently negative at the concentration of colloidal gold cnjugated secondary 





RESULTS AND DISCUSSION 
In an effort to determine the localization of the C. burnetii T4BSS, IFA analyses 
using rabbit antibodies specific to IcmT, IcmV, and DotH was employed.  IFA 
microscopy of Vero cells heavily infected (3 weeks post infection) with C. burnetii NMII 
show bacterial cells with polar and bi-polar localization of the T4BSS proteins when 
probed with antibodies against C. burnetii IcmT (Figure 5.1, panels A and B), IcmV 
(Figure 5.1, panel C), and DotH (Figure 5.1, panel D) proteins, respectively.  Polar 
localization of the T4BSS proteins can clearly be seen in the enlarg d panels (Figure 5.1, 
panel B and panels C and D insets, arrows).  While cell specific localization was difficult 
to differentiate in densely populated PVs, polarity was readily detectable in spacious PVs 
(Figure 5.1, panel A) and with individual C. burnetii cells (Figure 5.1, panels C and D).  
Heavily infected cells were used in this analysis in order to capture all aspects of the 
infectious cycle.  While IcmT is detectable at 0 hours post infection (hpi) (defined as the 
end of a 2 hour inoculation, Morgan et. al, submitted), the polarity is not clearly 
discernable.  However, polarity is clear in IFAs using antibodies to IcmT by 8 hpi (Figure 
5.1, panel E) and can be observed throughout the infectious cycle (and data not shown).  
In addition, I observed bi-polar localization in approximately 60% of the cells where 
polarity was observed (Figure 5.1, panel B). 
To confirm the fluorescent microscopy observations, I analyzed C. burnetii 
infected Vero cells using immunoelectron microscopy (IEM) with C. burnetii IcmT, 
IcmV, and DotH specific antibodies.  IEM analyses revealed polar localization of the 
gold-particle conjugated anti-rabbit antibodies to one and/or both polesof the bacteria 





Figure 5.1:  IFA localization of Coxiella burnetii NMII IcmT, IcmV, and DotH.  Panel A, 
Merged IFA micrograph showing whole C. burnetii cells in red (goat anti-guinea pig 
Alexa 555), IcmT in green (goat anti-rabbit Alexa 488), and Vero cell nucleus in blue 
(DAPI stain).  Panel B, enlargement of Panel A, pink squared area.  Panels C, merged 
image detecting IcmV localization, and Panel D, merged image detecting DotH 
localization.  Panel E, merged IcmT showing polar localization by 8 hours post infection.  
Enlargements of three cells are shown within inset panels (red, yellow, and pink squares) 





Figure 5.2:  IEM localization of Coxiella burnetii NMII IcmT and DotH.  Panels A and B 
- Representative cryo-IEM micrographs of C. burnetii cells probed with antibodies to 
IcmT.  Panels C and D - Representative low temp-IEM micrographs of C. burnetii cells 
probed with antibodies to DotH.  Black arrows indicate immune-gold particles at the ends 






IcmT and DotH show both single and bi-polar expression in cells that appear to be LCVs 
(Figure 5.2), based on an LCV length of 0.5 to 1.0µm [120, 122, 275].  Multiple a tempts 
and technical approaches to obtain conclusive IEM results for IcmV localization were 
unsuccessful.  However, the conclusive results for both IcmT and DotH prvided us with 
evidence of polar localization of the C. burnetii T4BSS.  These IEM data support the 
results observed by IFA for both IcmT and DotH localization patterns (Figures. 5.1 and 
5.2) as well as IcmV localization observed by fluorescent microscopy. 
Using Vero cells heavily infected with C. burnetii NMII allowed for ready 
identification of polarity by IEM however, biological questions remain about the 
morphology of the T4BSS.  For instance, it remains to be determined whether the C. 
burnetii T4BSS initially localizes medial to the polar regions to then migrates lateral to 
the poles during the course of cellular development, or whether it initially nucleates at the 
pole(s) and recruits sequential components to the nucleation site.  In addition, IFA 
demonstrating the presence of IcmT by 0 hpi raises the question as t  whether SCVs have 
a functional T4BSS at the outset of infection.  It may be that a functional C. burnetii 
T4BSS is carried over from the previous LCV to SCV conversion event or it arises from 
de novo expressed proteins produced very early in infection.  It may be that both 
scenarios may exist simultaneously.  It is interesting that I observe bacteria with T4BSSs 
on one or both poles.  The bi-polar localization of the T4BSS on C. burnetii cells may 
correlate to cells that are approaching cell division.  This would ensur  that progeny cells 
are each equipped with a functional T4BSS after binary fission.  This would imply that 
bacteria with T4BSS at a single pole are the result of a recent bacterial cell division 




The utility of having the T4BSS expressed on the pole(s) of the C. burnetii cells 
and how this may relate to the pathogens interactions with the host cell through the PV 
membrane is not clear.  The observation that  A. umefaciens intimately interfaces with its 
host cell at the bacterial pole [268] and that its T4ASS machinery th n secretes effectors 
into the host  [194] would indicate that direct association of a T4SS with a membrane 
may allow effector secretion across/into the membrane.  An analogous interface between 
pathogen and membrane has been observed in the intra-vacuolar bacteria Chlamydia 
trachomatis, which secretes effector proteins into the host cell via a T3SS [276] and 
closely associates with the PV (inclusion) membrane during infect on [277, 278].  An 
obvious and consistent interface between a pole of C. burnetii and the PV membrane has 
not been reported.  However, a study of published EM micrographs [129, 275] as well  
my own (Figure 5.3) indicates that there are instances where the poles of C. burnetii 
contact the PV membrane.  Whether these are simply random events, or whether the 
transient association of the bacterial pole with the PV would allow C. burnetii to secrete 
effector proteins into/through the PV membrane remains to be determined. 
In summary, my studies provide the first evidence that the C. burnetii T4BSS 
localizes at one or both poles of the bacterium during infection.  The combined IFA and 
IEM analyses revealed C. burnetii with single-pole or bi-polar expression of the T4BSS 
homologs IcmT, IcmV, and DotH.  However, the purpose(s) for polar expression of the 
C. burnetii T4BSS as it relates to the ability of the pathogen to secret  effector proteins 





Figure 5.3:  Electron micrograph of Coxiella burnetii infected Vero cell with densely 
packed PV.  Box Inset: Arrows (black) designate C. burnetii cells in polar contact relative 







SUMMARY REVIEW OF: 
ANALYSIS OF THE COXIELLA BURNETII TYPE IV SECRETION SYSTEM 





Coxiella burnetii is a Gram-negative obligate intracellular bacterial pathogen that 
is the causative agent of the zoonotic disease Q fever [12].  C. burnetii has two main 
forms.  The first is the metabolically inert SCV and the second is the metabolically active 
large LCV [120].  Though both forms are infectious in vitro [122, 128], the SCV is 
widely recognized as the form implicated in naturally acquired Q fever infections  [122].  
Typical, naturally acquired Q fever occurs as SCV cells are inhaled into the lungs of the 
host where it is then endocytosed by alveolar macrophages.  Once endocytosed by the 
host cell, the SCV containing vesicle is trafficked down the endocytic pathway where it 
becomes acidified by lysosomal fusion, thereby becoming a phagolysos me.  This C. 
burnetii containing phagolysosome is known as a parasitophorous vacuole (PV).  As the 
pH of the PV lowers, C. burnetii detects this change and begins a metabolic shift from 
SCV to the LCV developmental form [122]. 
The sequence of the C. burnetii Nine Mile phase I (RSA 493) genome revealed 
significant homology to the Legionella pneumophila Dot/Icm type IV secretion system 
[137].  The type IV secretion system category is defined by modern equivalents that are 
ancestrally related to ancient conjugation machinery which have been modified to deliver 
pathogenic virulence factors (e.g., effector proteins and/or protein/nucleotide complexes) 
[194, 196, 199].  The type IV secretion category has been divided into two subdivisions, 
type IVA and IVB [194].  Type IVA systems are homologous to the Agrobacterium 
tumefaciens VirB/D4 secretion system [194, 231, 232], while type IVB secretion systems 
have homology to the L. pneumophila Dot/Icm system [248].  Both type IVA [199, 232, 
235] and IVB [202, 203, 244-248] systems have been shown to be essential pathogenic 




has been shown that exist primarily on two loci designated Regions I (RI) and II [137].  
Little is known about these regions and the role they play in establishing and/or 
maintaining C. burnetii infections.  The C. burnetii Dot/Icm type IV RI contains open 
reading frames (ORFs) that are arranged in three directional groups:  
(i) icmX ←CBU1651←icmW 
(ii ) icmV→dotA→CBU1647 
(iii ) CBU1646←dotB←dotC←dotD←icmS←icmT 
Considering the ORF orientations, I hypothesized that these C. burnetii RI ORFs were 
co-transcribed as operons and that they are temporally regulated bo h transcriptionally 
and translationally over the course of infection.   
The obligate intracellular lifestyle of C. burnetii has limited RNA transcriptional 
studies to analyses using total RNA harvests.  Consequently, the vast majority of the 
RNA preparations contain predominantly eukaryotic host RNA species.  The prevailing 
eukaryotic host cell RNA found within total RNA harvests significantly limits the 
analyses that may be performed with respect to C. burnetii specific transcriptional 
studies.  Here I demonstrated a modified digitonin lysis technique which combined the 
stabilizing effects of GeneLock™ (Sierra Molecular) with ice pr servation to yield high 
quality RNA that is significantly enriched (p < 0.05) for C. burnetii specific RNA relative 
to conventional total RNA preparations.  This method allowed us to perform RT-PCR 
studies at earlier time points during infection than were previously possible without the 
enriched C. burnetii RNA.  Additionally, this technique should provide a means whereby 
previously impractical C. burnetii specific RNA analyses such as microarray and 




To characterize the transcriptional and translational regulation of the C. burnetii 
Dot/Icm type IV RI ORFs, I analyzed temporal expression profiles of RNA and protein 
for specific RI genes over a time course of infection.  To assess RNA regulation, I 
performed synchronous C. burnetii infections of host Vero cells from which RNA was 
harvested at early, mid, and late stages of infection, and analyzed these by RT-PCR and 
RT-qPCR.  By RT-PCR, I demonstrated that each of the three RI directional ORF groups 
were co-transcribed as operons.  Additionally, I showed that by 8 hpi, de novo RNA 
transcription was detectable for each of these three operons.  Using RT-qPCR, I 
demonstrated significant (p < 0.05) up and down regulation of transcriptional activities 
within the first 48 hpi for each of the three RI operons.  I also showed that relative 
uniform transcription trends followed from 48 to 168 hpi for each of the thr e operons.  
Subsequent to this, I demonstrated by indirect immunofluorescent antibody assa  (IFA) 
the protein expression profile of the RI encoded protein IcmT over the time course of 
infection.  The IcmT protein showed a regulatory trend that tightly correlated with the 
temporal transcription of the icmT gene.  Combined, these data demonstrate temporal 
regulation of both RNA and protein expression within the C. burnetii Dot/Icm type IV RI 
genes, and that these events appear to coincide with C. burnetii SCV conversion to LCV 
and back to SCV. 
The findings that the C. burnetii T4BSS RI is temporally regulated at both the 
RNA and protein level, in addition to my discovery that the C. burnetii T4BSS is 
expressed in the bacterial pole(s), provides novel answers to questions concerning C. 
burnetii-host cell interactions while posing additional questions, vis-à-vis C. burnetii 




the host come.  The flurry of transcriptional activity of theC. burnetii T4BSS RI genes at 
early time points (0 to 24 hpi) may well be related to the pathogens need to shape its 
intravacuolar niche into an environment suitable for its replication before it is digested by 
the cells normal innate phagolysosomal mechanisms.  To discover the physical properties 
and functions of the C. burnetii T4BSS as it relates to these biological events will lead to 
a more full understanding of C. burnetii parasitism specifically and bacterial interactions 
with host cells in a broader sense. 
It has been previously reported that type IV secretion system components and/or 
substrates appear to localize polarly in bacteria containing either typ  IVA [236, 237, 
239] or IVB [210, 241-243] secretion systems.  Using antibodies developed to 
recombinant C. burnetii IcmT, IcmV, and DotH proteins, I investigated the sub-cellular 
localization of the C. burnetii Dot/Icm type IV secretion system by IFA and 
immunoelectron microscopic (IEM) analyses.  Utilizing these methods, I was able to 
identify direct visual evidence showing C. burnetii type IV homologs IcmT, IcmV, and 
DotH are polarly expressed on C. burnetii LCV cells within a Vero host cell background.  
To my knowledge, this is the first direct evidence for C. burnetii Dot/Icm type IV 
secretion system ultra-structural localization.  These data strongly suggest that the C. 
burnetii Dot/Icm type IV secretion system complex localizes polarly in the metabolically 
active C. burnetii LCV cells. 
With respect to the finding that the C. burnetii T4BSS is localized to the bacterial 
pole(s), a combined study using IFA and IEM analyses over the time course of infection 
may provide evidence of protein specific T4BSS ultra-structural membrane localization, 




host/parasite T4BSS PV during infection.  It is not clear at this time whether bacteria with 
the T4BSS at one pole are the result of bipolar cells that divide, or the result of an 
independent T4BSS formation event at the pole itself. The possibility also exists that the 
T4BSS is assemble on the bacterial side and migrates to the as the peptidoglycan layer is 
made at the midline of the bacteria.  The functional advantage of a polarly expressed C. 
burnetii T4BSS is not clear, but may well be related to the pathogens ability to interact 
with the PV.  The possibility of an intimate T4BSS/PV membrane interface may well 
explain how bacterial proteins secreted within a membraneous vacuole are delivere  to 
the host cell cytoplasm as well as other organelles.  Conversely, should a stable interface 
with the PV not present itself, it may suggest that the effector molecules hav  the ability 
to transverse the PV membrane subsequent to T4BSS secretion into the PV lumen by 
some yet discovered means. 
Further study of the SCV and LCV forms of C. burnetii by IEM and IFA may 
well reveal whether the infectious SCV form is prepared to immediately begin s creting 
effector proteins via the T4BSS upon contact with a eukaryotic cell, or whether the 
T4BSS is present in non-functioning individual protein components, or whether it is 
absent altogether and has to be de novo synthesized upon infection.  The presence or 
absence of T4BSS in SCVs will have important implications respecting C. burnetii 







 The combination of digitonin lysis with GeneLock™ performed on ice 
significantly enriches the relative quantity and quality of intracellular specific 
bacterial RNA. 
 
 The Coxiella burnetii Dot/Icm type IV Region I contains 3 operons that are 
expressed and coordinately regulated over the time course of infectio  as the 
bacteria shifts from SCV to LCV and back to SCV. 
 
 Coxiella burnetii Dot/Icm type IV Region I protein expression increases 
significantly early during infection and correlates to Region I RNA expression. 
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